document type sequence filename description exhibit text html head title title head body style font time roman time serif style margin nbsp style margin text align right margin bottom exhibit style margin nbsp style font time roman time serif margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission style font time roman time serif margin margin bottom text align center nbsp style font time roman time serif margin margin bottom text align center pharmaceutical product development style font time roman time serif margin margin bottom text align center license agreement style font time roman time serif margin margin bottom text align center nbsp style font time roman time serif margin margin bottom text align center between style font time roman time serif margin margin bottom text align center nbsp style font time roman time serif margin margin bottom text align center cancer prevention pharmaceutical style font time roman time serif margin margin bottom text align center nbsp style font time roman time serif margin margin bottom text align center style font time roman time serif margin margin bottom text align center nbsp style font time roman time serif margin margin bottom text align center tillotts pharma style font time roman time serif margin margin bottom text align center nbsp style font time roman time serif margin margin bottom text align center december style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align center table content style font time roman time serif margin text align center nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style background color colspan style vertical align text decoration underline font style font size article nbsp nbsp recital font style vertical align bottom text align right font style font size font style background color white style vertical align width nbsp style vertical align width nbsp style vertical align bottom text align right width nbsp style background color colspan style vertical align text decoration underline font style font size article nbsp nbsp grant license right font style vertical align bottom text align right font style font size font style background color white style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color style vertical align font style font size section font style vertical align font style font size grant license under licensed patent font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size grant license licensed information font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size exclusivity font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size matter regarding licensed field licensed territory font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size right power sublicense font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size right first negotiation field outside licensed field font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size registration agreement font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size term font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size license companion diagnostics font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size further right license font style vertical align bottom text align right font style font size font style background color style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color white colspan style vertical align text decoration underline font style font size article nbsp nbsp transfer treatment licensed information font style vertical align bottom text align right font style font size font style background color style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color white style vertical align font style font size section font style vertical align font style font size delivery font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size confidentiality regard licensed information font style vertical align bottom text align right font style font size font style background color white style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color colspan style vertical align text decoration underline font style font size article nbsp nbsp development joint steering committee commercialization font style vertical align bottom text align right font style font size font style background color white style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color style vertical align font style font size section font style vertical align font style font size development plan font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size joint steering committee font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size decision making authority font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size commercialization font style vertical align bottom text align right font style font size font style background color style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color white colspan style vertical align text decoration underline font style font size article nbsp nbsp financial term font style vertical align bottom text align right font style font size font style background color style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color white style vertical align font style font size section font style vertical align font style font size license issue font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size development milestone payment font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size milestone font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size continued development font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size earned royalty font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size sale milestone payment font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size periodic report payment book record font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size payment procedure font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size late payment font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size tillotts rsquo audit right font style vertical align bottom text align right font style font size font table style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style background color colspan style vertical align text decoration underline font style font size article nbsp nbsp intellectual property right patent prosecution font style vertical align bottom text align right style background color white style vertical align width nbsp style vertical align width nbsp style vertical align bottom text align right width nbsp style background color style vertical align font style font size section font style vertical align font style font size data font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size intellectual property right font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size license grant font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size miscellaneous font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size prosecution font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size patent extension term restoration font style vertical align bottom text align right font style font size font style background color style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color white colspan style vertical align text decoration underline font style font size article nbsp nbsp infringement misappropriation font style vertical align bottom text align right font style font size font style background color style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color white style vertical align font style font size section font style vertical align font style font size action party upon knowledge infringement misappropriation font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size rsquo right font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size tillotts rsquo right font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size university arizona join font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size discontinuance settlement font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size sharing award font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size indemnification font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size assignment font style vertical align bottom text align right font style font size font style background color white style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color colspan style vertical align text decoration underline font style font size article viii nbsp nbsp allocation risk font style vertical align bottom text align right font style font size font style background color white style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color style vertical align font style font size section font style vertical align font style font size responsibility font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size liability limitation thereof font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size warranty disclaimer font style vertical align bottom text align right style background color white style vertical align font style font size section font style vertical align font style font size defense third party claim font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size insurance font style vertical align bottom text align right font style font size font style background color white style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color colspan style vertical align text decoration underline font style font size article nbsp nbsp termination font style vertical align bottom text align right font style font size font style background color white style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color style vertical align font style font size section font style vertical align font style font size termination right font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size extraordinary termination right font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size action upon consequence termination font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size surviving obligation font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size effect termination this agreement sublicenses font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size reverter font style vertical align bottom text align right font style font size font style background color style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color white colspan style vertical align text decoration underline font style font size article font font style font size purchase restricted stock font style vertical align bottom text align right font style font size font style background color style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color white colspan style vertical align text decoration underline font style font size article nbsp nbsp miscellaneous font style vertical align bottom text align right font style font size font style background color style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color white style vertical align font style font size section font style vertical align font style font size agreement entirety font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size address notice font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size amendment this agreement waiver font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size applicable font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size assignment font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size compliance with severability font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size computation time font style vertical align bottom text align right font style font size font table style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style background color style vertical align width font style font size section font style vertical align width font style font size confidentiality font style vertical align bottom width text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size counterpart font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size dispute resolution font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size export font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size force majeure font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size independent contractor font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size third party beneficiary font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size patent marking font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size representation warranty font style vertical align bottom text align right font style font size font style background color white style vertical align font style font size section font style vertical align font style font size further assurance font style vertical align bottom text align right font style font size font style background color style vertical align font style font size section font style vertical align font style font size change control font style vertical align bottom text align right font style font size font style background color white style vertical align nbsp style vertical align nbsp style vertical align bottom text align right nbsp style background color colspan style vertical align text decoration underline font style font size article nbsp nbsp rule interpretation font style vertical align bottom text align right font style font size font style background color white colspan style vertical align text decoration none nbsp style vertical align bottom text align right nbsp style vertical align background color font style font size section font font style font size certain rule interpretation font style text align right vertical align bottom font style font size font style vertical align background color white font style font size section font font style font size definition font style text align right vertical align bottom font style font size font table style margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align background color white style text decoration underline width font style font size exhibit font style text decoration underline width font style font size patent right font style width font style font size nbsp font style vertical align background color white nbsp nbsp nbsp style vertical align background color white style text decoration underline font style font size exhibit font style text decoration underline font style font size font font style font size nbsp font style vertical align background color white nbsp nbsp nbsp style vertical align background color white style text decoration underline font style font size exhibit font style text decoration underline font style font size font font style font size nbsp font style vertical align background color white nbsp nbsp nbsp style vertical align background color white style text decoration underline font style font size exhibit font style text decoration underline font style font size definition font font style font size nbsp font style vertical align background color white nbsp nbsp nbsp style vertical align background color white style text decoration underline font style font size exhibit font style text decoration underline font style font size surviving obligation font font style font size nbsp font table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin margin bottom text align center pharmaceutical product development license agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent effective december ldquo effective date rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify cancer prevention pharmaceutical delaware corporation with office river road suite tucson united state ldquo rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin margin bottom margin left text indent text align justify style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify tillotts pharma company formed under switzerland with office baslerstrasse rheinfelden switzerland ldquo tillotts rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify good valuable consideration receipt sufficiency which hereby acknowledged enter into this agreement ldquo agreement rdquo forth below style font time roman time serif margin margin bottom text align center nbsp style font time roman time serif margin margin bottom text align center article style font time roman time serif margin margin bottom text align center recital style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section developing prophylactic therapy human with elevated risk cancer engaged development product that subject certain patent right clinical study data owned controlled that subject regulatory filing made style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section tillotts pharmaceutical company engaged world wide development manufacture commercialization pharmaceutical product human gastrointestinal field especially field inflammatory bowel disease irritable bowel syndrome various know proprietary mechanism targeted delivery formulation gastrointestinal tract style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section both party based licensed formulation desire join force develop obtain regulatory approval licensed product licensed territory manner extent forth this agreement that tillotts desire obtain from license under licensed patent licensed information development regulatory approval manufacture marketing sale licensed product licensed field licensed territory herein provided willing grant those license under term condition this agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin margin bottom text align center article style font time roman time serif margin margin bottom text align center grant license right style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section grant license under licensed patent effective date subject this agreement herewith grant tillotts assignable except provided section with respect tillotts rsquo right appoint affiliate section license under licensed patent solely develop licensed formulation market sell offer sell licensed product licensed territory licensed field import export such license right granted implied under patent application patent outside licensed patent they constituted from time time style font time roman time serif margin text align justify nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section grant license licensed information effective date subject this agreement herewith grant tillotts assignable except provided section with respect tillotts rsquo right appoint affiliate section license licensed field licensed information solely development licensed formulation labeling marketing sale seeking approval commercialization licensed product licensed territory licensed field license right granted implied under information know outside licensed information constituted from time time foregoing license includes limited right tillotts refer incorporate filing licensed territory regulatory dossier necessary tillotts obtain country licensed territory approval licensed formulation licensed field accordance with term article below style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section exclusivity reservation right style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font size subsection nature exclusivity except provided this section license granted under each section collectively ldquo license rdquo exclusive tillotts that agrees itself licensed patent well licensed information only such generally laid section below font font style font size otherwise expressly stated this agreement furthermore agrees grant third party another concurrently effective license licensed field under licensed patent sell offer sell licensed product licensed territory import licensed product into licensed territory during term this agreement licensed information labeling marketing sale seek approval commercialization licensed product licensed territory during term this agreement furtherance foregoing grant third party without first complying with requirement section another concurrently effective license under licensed patent licensed information develop seek approval with respect label market sell offer sell commercialize licensed formulation labeled intended administration treatment gastrointestinal disease licensed territory treatment indicated disease optional territory country font style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection reservation right reserve retains itself university arizona applicable with respect clause only right licensed field execute task obligation under licensed patent licensed territory licensed information licensed territory purpose developing licensed formulation purpose this agreement accordance with initial development plan defined subsection right practice under licensed patent licensed information related intellectual property right purpose field country outside licensed territory subject section below right practice under licensed patent licensed information related intellectual property right purpose field outside licensed field licensed territory right exercise right enjoy benefit under agreement with third party supply compound licensed formulation conduct study clinical trial licensed territory field purpose subject tillotts rsquo exclusive right stipulated this agreement pursuant arizona license university arizona ldquo university rdquo solely educational internal research purpose that portion licensed patent licensed information that university licensed together with right sublicense such right another institution higher education only inventor such licensed patent licensed information move such other institution collectively ldquo reserved right rdquo avoidance doubt this agreement exclusivity granted tillotts hereunder subject right united state government licensed patent reserved united state government under those derived through license right reserved granted granted united state government foregoing right license include inter alia certain exclusive transferable irrevocable paid license united state government governmental purpose behalf foreign government pursuant existing future treaty agreement with united state which license survives unaffected granting license right under this agreement this agreement expressly subject term condition applicable determination appropriate agency government concerning disposition licensed patent right issue license thereunder style font time roman time serif margin text align justify nbsp field page sequence option newsection value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section matter regarding licensed field licensed territory style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection addition indicated disease from time time tillotts request sole discretion accordance with definition indicated disease subparagraph particular distinctly identified gastrointestinal disease indicated disease that request must take form written notice sent ldquo disease addition notice rdquo that identifies with reasonable particularity additional gastrointestinal disease that subject request specifies reasonable plan obtaining approval licensed territory treatment additional gastrointestinal disease estimated time frame under which tillotts intends commence implement that plan ldquo supplemental disease development plan rdquo promptly after rsquo receipt disease addition notice party will commence diligent exclusive negotiation good faith minimum hundred eighty otherwise agreed directed execution written amendment this agreement ldquo disease addition amendment rdquo specifying each party rsquo obligation with respect supplemental disease development plan avoidance doubt absent express provision disease addition amendment contrary commencement conduct supplemental disease development plan will tillotts rsquo sole discretion election tillotts conduct supplemental disease development plan will breach this agreement also avoidance doubt event that tillotts stop supplemental disease development plan based supplemental product competing with already existing product stemming from development under this agreement then unless otherwise expressly stated supplemental disease development plan shall have right directly indirectly take over work previously carried tillotts continue work regard stopped supplemental disease development plan style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection expansion licensed territory from time time sole discretion before sixty after provided tillotts with proposed country license notice defined immediately below tillotts request expand licensed territory adding more optional territory country licensed territory style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify ldquo proposed country license notice rdquo mean notification from tillotts that wish exploit grant license under licensed patent licensed information develop seek approval sell offer sell licensed formulation licensed field more optional territory country that have been previously added licensed territory forth hereunder style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify such request expand licensed territory made tillotts must take form written notice ldquo country addition notice rdquo that identifies with reasonable particularity optional territory country that subject request specifies reasonable plan approval licensed field specified optional territory country time frame under which tillotts intends commence implement that plan expense ldquo supplemental country development plan rdquo promptly after rsquo receipt country addition notice party will commence diligent exclusive negotiation good faith minimum ninety otherwise agreed directed execution written amendment this agreement ldquo country addition amendment rdquo which licensed territory will expanded adding such additional optional territory country licensed territory specifying each party rsquo obligation with respect supplemental country development plan although neither party obligated agree such amendment country addition amendment must also address termination supplemental country development plan consequence termination upon addition optional territory country licensed territory optional information pertaining that country will deemed included licensed information avoidance doubt absent express provision country addition amendment contrary commencement conduct supplemental country development plan will tillotts rsquo sole discretion election tillotts conduct supplemental country development plan will breach this agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text indent subsection party rsquo joint effort exploring utilization licensed product outside indicated disease style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent party herewith confirm their understanding that each party interested exploring utilization licensed product licensed field licensed territory outside indicated disease therefore during term agreement party shall discus good faith possible development suitable business model regard commercialization such potential product including idea that party generate discus with interested third party this regard party shall inform other about such idea interested third party first round party shall convene discus underlying preliminary data shall decide good faith whether gather more detailed data order eventually decide about possible commercial exploration including development should party able mutually agree commercial exploration party herewith confirm their understanding that such activity licensed field licensed territory outside indicated disease shall pursued either party future style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection covenant consideration exclusivity granted hereunder tillotts covenant agrees that during term will limit exercise right under license licensed field within licensed territory they constituted from time time without limiting generality foregoing furtherance thereof tillotts covenant agrees that affiliate sublicensees will practice under licensed patent licensed information develop manufacture seek obtain approval market sell commercialize directly indirectly product pharmaceutical formulation outside licensed field outside licensed territory they constituted from time time licensed territory seek obtain approval sell commercialize directly indirectly product pharmaceutical formulation approved treatment prevention indicated disease other than licensed product tillotts expressly covenant that tillotts affiliate sublicensees will sell licensed product licensed territory tillotts affiliate sublicensee case know reasonably should know that those licensed product will distributed sold outside licensed territory outside licensed field style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section right power sublicense style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection specifically regard tillotts rsquo affiliate herewith approves that tillotts rsquo affiliate fall under definition ldquo sublicensee rdquo used throughout agreement herein after appointed tillotts carry certain task obligation forth subject this agreement provided that tillotts notifies writing within thirty after such appointment including such notice name affiliate task obligation which been appointed tillotts tillotts during term this agreement will remain liable action omission wrongfully made affiliate such action omission were those tillotts style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection generally subject rsquo prior written approval within thirty after receiving written request from tillotts such approval unreasonably withheld third party that proposed tillotts sublicensee which avoidance doubt excludes affiliate tillotts forth immediately above section tillotts grant third party assignable sublicenses licensed field licensed territory under license that comply with this agreement tillotts right power grant sublicenses only effect while license effect during term tillotts material breach this agreement exercised only extent license exclusive tillotts with exception affiliate tillotts third party sublicensee have right power grant further sublicense other further right power sublicense hereby granted implied this agreement terminated such sublicenses assigned accordance with section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection requirement tillotts shall commercially reasonable effort perform diligence potential sublicensees evaluate whether each such potential sublicensee compliance with applicable anti corruption including bribery require each sublicensee comply with applicable anti corruption including bribery corporate anti corruption policy tillotts tillotts shall cooperate good faith with with respect monitoring enforcing anti corruption policy including providing with access information obtained from tillotts rsquo compliance related audit sublicensees tillotts must provide written notice issuance each sublicense true copy within sixty after execution each sublicense sublicenses shall issued english copy sublicense provided tillotts redact those portion sublicense that required provide assurance that sublicense compliance with this agreement that otherwise pertain term this agreement each sublicense must writing must include provision similar effect scope material respect those this agreement each sublicense must comply with applicable governmental regulation particular tillotts grant shall refuse grant sublicense under circumstance term condition amounting misuse licensed patent tillotts responsible complying with obligation this agreement based activity sublicensee including paying earned royalty respect activity sale licensed product sublicensees time during term tillotts will remain liable action omission wrongfully made party having been granted sublicense tillotts permitted applicable must name intended third party beneficiary with full right enforce sublicensee rsquo obligation thereunder terminate that sublicense breach sublicense under provision similar that provided subsection avoidance doubt enforce such right mentioned only tillotts unreasonably refused against such sublicensee that breach obligation itself meaning that must always discus agree action that intends take against sublicensee with tillotts first style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section right first negotiation field outside licensed field style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection definition ldquo pediatric cancer rdquo mean treatment cancer first diagnosed treated patient ndash year including neuroblastoma medulloblastoma that primary gastrointestinal cancer ldquo proposed outside field license rdquo mean license under licensed patent licensed information sell offer sell licensed formulation labeled intended administration licensed territory prevention treatment more disease that gastrointestinal disease pediatric cancer ldquo term sheet period rdquo mean period beginning date receives rofn notice defined below ending date sixty thereafter ldquo license negotiation period rdquo mean period ending date hundred twenty after receipt corresponding draft license agreement negotiate good faith term subject proposed outside field license style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection rofn proposed outside field license during term this agreement intends solicit third party negotiate grant third party other than affiliate proposed outside field license must provide tillotts written notice that intent including information whether envisioned proposed outside field license would distinct formulation interchangeable formulation reference subsection ldquo outside field notice rdquo before solicit third party negotiate take that proposed outside field license hereby grant tillotts first right negotiate exclusively with regarding proposed outside field license ldquo right first negotiation rdquo ldquo rofn rdquo before date sixty after tillotts rsquo receipt outside field notice tillotts must provide written notice ldquo rofn notice rdquo tillotts elect exercise rofn with respect that proposed outside field license tillotts decline outside field notice writing tillotts fails timely provide that rofn notice fault then tillotts will deemed have declined exercise rofn with respect proposed outside field license grant such proposed outside field license third party without further obligation tillotts except required pursuant section provided however that tillotts decided decline outside field notice deemed decline based formulation contained applicable outside field notice such proposed formulation identified such outside field notice change from distinct formulation interchangeable formulation reverse then shall provide tillotts updated outside field notice tillotts provide rofn notice unless before date updated outside field notice agreed with third party negotiate exclusively with respect such proposed outside field license rsquo provision updated outside field notice would breach rsquo obligation third party including obligation confidentiality event that clause clause applies then shall have obligation provide tillotts updated outside field notice grant such proposed outside field license such third party tillotts timely provides rofn notice tillotts must negotiate good faith execute before expiration term sheet period otherwise agreed binding term sheet ldquo rofn term sheet rdquo specifying salient term proposed outside field license rofn term sheet timely executed then tillotts must negotiate good faith execute before expiration licensed negotiation period subject proposed outside field license tillotts declined deemed have declined exercise rofn with respect proposed outside field license before expiration term sheet period tillotts have executed rofn term sheet before expiration license negotiation period tillotts have executed pertinent proposed outside field license then rofn will expire further effect regard pertinent outside field notice grant such proposed outside field license third party subject subsection provided however that term such proposed outside field license with third party taken whole including risk adjusted present value future payment favorable than tillotts rsquo last offer then must offer tillotts such favorable term writing ldquo right first refusal notice rdquo ldquo rofr notice rdquo tillotts shall have thirty from date such rofr notice ldquo rofr acceptance period rdquo delivered accept such term writing without modification tillotts fails notify such acceptance before rofr acceptance period then grant such proposed outside field license third party such term term more favorable subject only tillotts rsquo right under section style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection distinct interchangeable formulation style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small distinct formulation font font style font variant small font proposed outside field license pertains distinct formulation such ultimately fall under subsection party either timely execute rofn term sheet tillotts accept rofr notice within rofr acceptance period applicable license agreement with regard proposed outside field license then will free grant third party proposed outside field license that subject rofn notice style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small interchangeable formulation font font style font variant small font party unable timely agree upon salient term rofn term sheet tillotts accept rofr notice within rofr acceptance period applicable proposed outside field license before expiration term sheet period license negotiation period proposed outside field license would permit development interchangeable formulation licensed territory grant proposed outside field license third party unless either tillotts provides written consent grant proposed license which consent unreasonably withheld agrees earned royalty respect sale licensed formulation under proposed outside field license provided below tillotts provide written consent within sixty rsquo written request therefor then tillotts must provide before conclusion that sixty period written analysis that tillotts belief demonstrates that marketing sale interchangeable formulation under proposed outside field license would likely substantially reduce tillotts rsquo sale licensed formulation primary indication licensed territory tillotts fails timely provide written analysis tillotts will deemed have granted written consent before date thirty after receives tillotts rsquo written analysis notifies tillotts detail that disagrees with tillotts rsquo demonstration likely substantial reduction those sale then party will submit matter valuation expert panel defined below which will promptly determine whether tillotts rsquo analysis reasonably demonstrates likely substantial reduction sale which determination will binding party valuation expert panel determines that tillotts failed reasonably demonstrate that likely substantial reduction then will free grant proposed outside field license without tillotts rsquo written consent within thirty period following rsquo receipt tillotts rsquo written analysis fails notify tillotts that disagrees with tillotts rsquo demonstration forth written analysis will deemed have accepted tillotts rsquo determination valuation expert panel determines that tillotts failed demonstrate such likely substantial reduction interchangeable formulation such interchangeable formulation distinct formulation that subject proposed outside field license actually launched licensed territory tillotts belief that such sale interchangeable formulation such distinct formulation have caused actual reduction tillotts rsquo sale licensed formulation primary indication disease licensed territory least since such interchangeable formulation such distinct formulation applicable launched compared average equivalent period during immediately prior three year this percentage understood trigger point starting discussion mentioned immediately herein below then tillotts time between such launch date that twelve month after first launch meaning first commercial availability such interchangeable formulation such distinct formulation country within licensed territory ldquo post launch period rdquo notify such actual reduction including with such notice evidence such reduction ldquo reduced sale notice rdquo tillotts shall meet good faith discus whether what extent such sale have been reduced cause such reduction agree with tillotts rsquo determination then notwithstanding prior decision valuation expert panel with respect interchangeable formulation tillotts upon written notice time during post launch period date that ninety thereafter submit such matter additional time case such distinct formulation first time valuation expert panel final determination pursuant subsection based actual data including data related sale licensed product market share data licensed product interchangeable formulation distinct formulation style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent font style font variant small field license interchangeable distinct formulation with royalty font font style font variant small font under paragraph above concurs valuation expert panel determined that tillotts reasonably demonstrated that marketing sale licensed formulation under proposed outside field license will likely substantially reduce actually substantially reduces sale licensed product licensed territory notify tillotts writing that nonetheless elect solicit third party grant third party proposed outside field license subject rsquo payment earned royalty other compensation respect sale licensed formulation under proposed outside field license promptly thereafter tillotts must negotiate good faith term amendment this agreement under which would tillotts such earned royalty compensation earned royalty other compensation will rate level that designed compensate tillotts reduction profit associated with likely actual applicable substantial reduction sale licensed product licensed territory party unable agree upon that royalty rate other compensation before date sixty after date which submits first proposal tillotts then party must submit matter valuation expert panel final determination that earned royalty other compensation follows each party must submit best final offer valuation expert panel along with supporting evidence argumentation manner established valuation expert panel later than thirty after appointment final valuation expert valuation expert panel valuation expert panel must award only other best offer submitted earned royalty rate part such compensation will report quarterly sale under proposed outside field license same manner provided subsection mutatis mutandis style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent font style font variant small valuation expert panel font font style font variant small font matter submitted under this agreement valuation expert panel shall submitted decided pursuant clause clause this section ldquo valuation expert panel rdquo which avoidance doubt differs from ldquo expert panel rdquo forth section will consist three independent expert analysis valuation pharmaceutical pharmaceutical market order facilitate rapid resolution matter submitted valuation expert panel each party must within month after effective date such other date party mutually agree choose expert willing serve valuation expert panel third expert must chosen other expert within sixty after date which both first expert have been chosen party fails choose valuation expert within month after effective date such other date party mutually agree then party will deemed have waived right choose expert valuation expert panel will comprised solely timely chosen expert expert appointed party unable timely agree third expert then either party refer matter pursuant section sole purpose selecting such third expert member valuation expert panel becomes unwilling unable serve such capacity then applicable party that appointed such member shall promptly appoint replacement case third expert replacement shall chosen provide above each party responsible expense incurred appointee valuation expert panel party must each expense third member valuation expert panel promptly upon receipt that third member rsquo invoice valuation expert panel will free engage inter partes communication with party deem desirable necessary inform itself regarding issue before valuation expert panel will endeavor consensus consensus reached determination valuation expert panel will made majority valuation expert style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection pediatric cancer clarity section right first negotiation field outside licensed field apply pediatric cancer develop commercialize distinct formulation pediatric cancer licensed territory with obligation tillotts develops interchangeable formulation pediatric cancer then rsquo sale such interchangeable formulation licensed territory shall subject payment tillotts royalty such sale which each party rsquo senior management shall negotiate good faith order compensate tillotts reasonably anticipated lost sale caused sale interchangeable formulation licensed territory party reach such agreement within ninety after date that such interchangeable formulation first launched licensed territory then either party written notice other party require that such royalty rate determined valuation expert panel constituted accordance with section whose decision shall final binding party style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section registration agreement each party must take reasonable necessary step register this agreement abbreviated version existence thereof advised tillotts rsquo regulatory counsel each sublicense country licensed territory where registration required permit payment royalty from party other case under this agreement evidence grant exclusive right under this agreement tillotts satisfy legal governmental requirement country licensed territory effectuate carry this agreement neither party will relieved obligation under this agreement because failed register this agreement tillotts responsible filing other cost expense including attorney rsquo that incurred registration this agreement licensed territory style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section term unless earlier terminated this agreement license will automatically expire date time which royalty term expires licensed product country licensed territory ldquo term rdquo upon expiration this agreement country country licensed product licensed product basis license licensed field will fully paid perpetual irrevocable only country country licensed product licensed product basis country licensed territory then constituted expiration termination this agreement constitute termination waiver right either party against other party accruing prior time expiration termination terminate waive either party surviving obligation under this agreement without limiting generality foregoing each party rsquo surviving obligation report other party royalty under this agreement shall survive expiration this agreement avoidance doubt tillotts must continue report until reconciliation difference between actuals estimate discount contra revenue item related sale licensed product before termination expiration this agreement required under subsection completely exhausted style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section license companion diagnostics event that approval licensed product contains restriction labeling requirement pricing reimbursement body consider benefit that licensed product administered only after conduct genetic test then grant tillotts exclusive assignable limited license develop register make sell offer sell diagnostic license product licensed territory support connection with tillotts rsquo sale licensed product under this agreement party agree discus good faith whether development companion diagnostic advisable discus good faith term under which would grant tillotts such license before event described clause clause previous sentence royalty determination will discussed good faith between party time party unable agree either party submit royalty determination valuation expert panel accordance with subsection remains free grant third party right license develop market sell diagnostic licensed product principal part their business develop register market sell such companion diagnostic development diagnostic licensed product such third party requires grant exclusive license termination license granted under this section then tillotts unreasonably withhold delay consent termination thereof case must secure availability tillotts sale tillotts companion diagnostic test connection with support development registration marketing sale licensed product style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section further right license except expressly provided this agreement including article section subsection further different license sublicense option right granted tillotts implied additional right hereunder deemed granted estoppel otherwise addition right expressly reserved under section subsection reserve itself other right expressly exclusively granted herein including collectively independently right relation country outside licensed territory right field outside licensed field right licensed territory exclusively expressly granted tillotts under this agreement effective date right licensed field exclusively expressly granted tillotts under this agreement style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align center article style font time roman time serif margin text align center transfer treatment licensed information style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section delivery extent already done promptly following effective date from time time thereafter during term will timely provide tillotts licensed information including owned data defined section which store digital repository established part initial development plan ldquo repository rdquo time tillotts reasonably request that delivery licensed information will initially made read only format repository from which licensed information data including limited owned data other clinical regulatory information exchanged between party will made available electronic transmission download digital repository that tillotts discretion establish ldquo tillotts repository rdquo tillotts shall bear cost establishing maintaining tillotts repository shall control content thereof subject section tillotts will determine sole discretion with information necessary password user code change thereto that necessary access tillotts repository notwithstanding anything this agreement contrary tillotts terminates this agreement pursuant subsection material breach pursuant subsection financial default then tillotts continue have access tillotts repository long license remain effect accordance with subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section confidentiality regard licensed information disclosure licensed information provision this section will supersede extinguish provision existing disclosure agreement between party regarding confidential treatment disclosed information licensed information transferred from tillotts before effective date will subject must treated tillotts accordance with provision this section style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection generally provision this section apply licensed information only whereas provision section apply confidential information other than licensed information except expressly permitted under subsection below during term this agreement time thereafter tillotts must treat that licensed information strictly absolutely confidential licensed information only purpose expressly permitted under this agreement except provided this subsection subsection below foregoing obligation restriction will expire date year after date which this agreement expires earlier terminated except case licensed information that maintains trade secret which case term foregoing obligation restriction will later year date specified above date which licensed information cease trade secret through fault tillotts those authorized under this agreement receive from tillotts foregoing restriction obligation apply that part licensed information that becomes generally known scientific community available seeking regulatory approval drug through fault tillotts those whom properly disclosed under this agreement being understood that subsequent general knowledge will excuse earlier breach this agreement licensed information will deemed generally known available third party seeking regulatory approval because contained filing made with governmental authority country including regulatory authority patent authority within licensed territory within patent drug regulatory authority country outside licensed territory style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent font style font variant small rsquo treatment licensed information font although licensed information remains solely owned recognition potential value tillotts resulting from confidential nature certain such licensed information will take reasonable step good faith discretion close consultation with tillotts protect licensed information using degree care that ordinarily such licensed information subject obligation that have right that third party have including pursuant clinical trial site agreement arizona license disclose certain licensed information rsquo obligation comply with applicable regulation including applicable security rule regulation applicable security exchange well following order court competent jurisdiction government agency properly exercising delegated authority which compels disclose licensed information provided however that foregoing shall prevent from disclosing licensed information rsquo reasonable business judgment such disclosure appropriate order exercise rsquo right develop licensed formulation outside licensed territory within licensed territory outside licensed field provide corporate partner investor lender potential corporate partner investor lender professional financial analyst information that deems relevant potential corporate transaction investment loan notwithstanding anything this agreement contrary recognizing that retains right licensed information outside licensed territory materially breach this subsection then tillotts rsquo sole remedy such breach shall monetary damage injunctive relief tillotts shall entitled terminate this agreement result breach this subsection clarity except this subsection obligation procedure described section apply style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection protective action permitted disclosure tillotts must protect licensed information from unauthorized disclosure misappropriation using same degree care protect other similarly sensitive confidential information trade secret than reasonable degree care tillotts disclose licensed information will limit access licensed information solely required further purpose approval licensed product licensed territory provide licensed information third party connection with grant sublicense then only disclosure divulgation subject legally binding written obligation agreement sublicensee maintain confidentiality licensed information limit licensed information manner extent least restrictive that forth this section those trusted representative require licensed information purpose tillotts rsquo enjoying right benefit license aware tillotts rsquo obligation restriction under this agreement each ldquo authorized representative rdquo disclosure authorized representative must kept minimum necessary that authorized representative perform duty effectively purpose this agreement only internal repository licensed information maintained tillotts server other central computer restriction access required hereunder other measure taken ensure confirm limited access must taken electronically style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection compelled disclosure tillotts additionally authorized recipient licensed information including sublicensee required disclose more element licensed information order court competent jurisdiction government agency properly exercising delegated authority tillotts that authorized recipient case must promptly inform writing those circumstance party shall reasonably consult with each other step taken avoid restrict disclosure give each other opportunity prevent disclosure quash order otherwise contest defend against limit ordered disclosure provided this information procedure possible given deadline ordered court government agency rsquo expense which includes indemnification penalty which tillotts might suffer because rsquo preventative action disclosure licensed information nonetheless required tillotts that authorized recipient case must endeavor place reasonable arrangement designed maintain confidentiality commercial value licensed information event must endeavor reasonably limit disclosure licensed information pursuant that order regulation minimum required comply with term notwithstanding permitted disclosure permitted under this subsection tillotts must continue treat disclosed licensed information accordance with this agreement other instance respect style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection unauthorized disclosure tillotts becomes aware that authorized recipient licensed information hereunder including sublicensee breached provision this section then tillotts must notify soon practicable party must promptly confer course action take appropriate under circumstance cure breach mitigate harm damage arising from case breach this section tillotts must promptly notify third party improperly receiving using licensed information that receipt licensed information unlawful must request third party promptly return licensed information agree further disclose purpose sole cost expense tillotts must assist cooperate with reasonable effort that type purpose this agreement tillotts rsquo ongoing obligation earned royalty under this agreement unauthorized disclosure licensed information tillotts authorized recipient thereof reduce tillotts rsquo obligation earned royalty hereunder will continue unaffected undiminished such unauthorized disclosure proven material breach provision this section authorized recipient licensed information will deemed breach tillotts this section tillotts must promptly reimburse cost expense reasonably directly incurred remedying unauthorized disclosure taking action protect right benefit from licensed information improperly disclosed mitigate damage harm arising from that improper disclosure style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection remedy licensed information valuable special unique constitutes trade secret give commercial competitive advantage because generally known readily available public those competing with thus tillotts authorized recipient breach threatens breach provision this section irreparably damaged injured such that remedy will afford adequate protection against appropriate compensation that damage injury accordingly notwithstanding section enforce provision this section equitable remedy including without limitation injunction specific performance although those remedy exclusive remedy under this agreement will addition other remedy available equity bring solely with respect breach threatened breach this section action seeking those remedy court united state state having subject matter jurisdiction tillotts hereby agrees submit jurisdiction such court hereby waif claim defense that there adequate remedy such breach threatened breach tillotts hereby waif requirement posting bond other collateral that required seek equitable relief tillotts will cause each sublicense contain provision substantially similar this section style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align center article style font time roman time serif margin text align center development joint scientific committee commercialization style font time roman time serif margin text align center nbsp style font time roman time serif margin text align justify text indent section development plan style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent content overall plan development licensed formulation primary indication disease licensed territory includes pertinent development activity respective responsibility associated cost applicable timeline estimated mutual agreement party time signing this agreement which generally laid exhibit hereto such amended mutual agreement ldquo initial development plan rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent initial development plan will serve guideline party rsquo effort developing licensed formulation sale under this agreement party agree coordinate carry accordance with subsection development activity agreed initial development plan such plan modified future subject tillotts rsquo timely payment payment required under article will cause phase clinical trial conducted trial site europe north america directed approval primary indication disease accordance with protocol attached hereto exhibit ldquo phase trial rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent performance acting pursuant initial development plan each party will expend devote effort resource that would used company size resource similar such party within pharmaceutical industry development pharmaceutical product which similar market potential similar stage development product life taking into account issue including safety efficacy product profile pricing reimbursement status proprietary position product comparison other product party rsquo product portfolio then prevailing regulatory environment status with respect hereto subject prerequisite condition specified implied initial development plan that applicable given task ldquo commercially reasonable diligence rdquo however neither party provides other party with assurance that particular result will achieved through their respective commercially reasonable diligence under initial development plan that task will successfully completed accordingly provided each party exercise commercially reasonable diligence required above failure successfully complete task forth initial development plan achieve certain result constitute breach under this agreement even case tillotts certain termination right with respect such failure under subsection extraordinary termination event style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent change recognition uncertain contingent nature initial development plan will regularly examine discus proceeding development compare initial development plan propose party modification update address resolved contingency unanticipated event outcome delay style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent notification order able respond adopt timely manner party executing salient activity task under initial development plan modified version shall inform other party about material deviation time determined cost relevant external condition timely manner style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection total development cost style font time roman time serif margin text align justify will bear total development cost that estimated effective date provided that total development cost exceed then subsection bridge financing total development cost deficiency payment describe tillotts rsquo sole obligation with respect sharing such additional total development cost style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent shall however remain responsible ensuring that sufficient fund available meet total development cost assist funding total development cost intends request tillotts such time determine appropriate extend line credit amount under term separately agreed which request tillotts shall consider good faith avoidance doubt understood obligation tillotts automatically extend line credit event that request such style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent however before date three month after completion entire phase trial must prepare submit final determination total development cost along with reasonable supporting documentation tillotts dispute rsquo final determination total development cost party will submit matter dispute resolution process forth section below style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent cost reporting ndash shall provide updated comparison between estimated total development cost actual spending quarterly basis meeting style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent obligation contribute portion japan development cost tillotts affiliate shall bear entirety japan development cost that itself with help third party style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent additionally shall inform tillotts time event that foresees that overall financial resource allow fulfilling rsquo obligation under this agreement more than additional three month style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection continued development election statistical analysis plan incorporated defined part protocol provides conduct interim futility assessment focusing analysis primary secondary endpoint order extent which combination compound daily sulindac more effective than each agent alone delaying time first related event familial adenomatous polyposis patient ldquo interim futility analysis rdquo interim assessment sample size ldquo interim sample size analysis rdquo interim futility analysis interim sample size analysis collectively ldquo interim analysis rdquo behalf data monitoring committee defined established pursuant protocol ldquo rdquo tillotts shall nominate member subject rsquo consent unreasonably withheld subject applicable regulation must secure preparation delivery more written report interim analysis including statement such report collectively ldquo interim analysis report rdquo that must latest after receipt deliver member after receipt before date sixty after date rsquo receipt complete interim analysis report tillotts must elect writing either terminate this agreement pursuant clause subsection extraordinary termination event commit continue support phase trial party rsquo development effort under this agreement latter election referred herein ldquo continued development election rdquo tillotts rsquo election including election terminate pursuant clause subsection extraordinary termination event must based interim analysis report which component statement issued that recommends termination phase trial primary indication disease increase number patient recruited pursuant protocol more tillotts timely make election tillotts will deemed have made continued development election tillotts make deemed make continued development election tillotts must continued development specified section before date thirty after date which tillotts make deemed make continued development election tillotts elect terminate this agreement must provide reasonably detailed summary basis reasoning termination accordance with requirement this subsection accordance with subsection below promptly comply with obligation upon termination under subsection style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection preparation submission prosecution style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small obligation submit condition submission font subject subsection below with respect japan promptly after conclusion phase trial completion task necessary submission under initial then current development plan case tillotts right obligation expense prepare file based acute prepared ectd equivalent acceptable tillotts obtain approval regard licensed formulation primary indication country licensed territory tillotts must exercise commercially reasonable diligence prosecuting obtaining approval based submission file necessary report timely fully respond request regulatory authority connection with those submission their review tillotts must exhaust administrative remedy reasonably available being understood that litigation other adversarial proceeding reasonably available remedy instance adverse action tillotts elect submit licensed formulation licensed territory opines that result phase trial suggest that approval reasonably possible subject subsection below with respect japan either party request that filing licensed territory deferred party requesting deferral demonstrates other party rsquo reasonable satisfaction that because change regulatory requirement since date conclusion phase trial prospect obtaining approval favorable pricing decision from applicable regulatory authority would substantially improve deferral date that submission party requesting deferral demonstrates other party rsquo reasonable satisfaction that necessary conduct additional study obtain approval licensed formulation licensed territory which event party must promptly commence good faith discussion inform each other regarding need purpose those study develop agree upon protocol govern them party rsquo respective obligation paying them being understood that neither party obligated agree upon protocol contribution cost those additional study notwithstanding tillotts rsquo election submit based rsquo recommendation regarding result phase trial tillotts rsquo request that submission deferred provided clause above submit acceptance regulatory authority without deferral related filing expense approval obtained based those filing then will tillotts rsquo expense assign resultant approval tillotts tillotts rsquo expense tillotts must reimburse cost those submission filing promptly after tillotts receives rsquo statement with supporting documentation expense thereof style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent font style font size font style font variant small review submission font generally connection with tillotts rsquo action furtherance foregoing right obligation before tillotts file with regulatory authority other written communication with regulatory authority connection with that tillotts must provide copy those written communication reasonably advance filing submitting same regulatory authority obtain rsquo comment filing tillotts shall duly consider comment made subject rsquo comment subject transfer sponsorship described next sentence tillotts will responsible expense interfacing corresponding meeting with regulatory authority connection with filing prosecution each filed licensed territory must keep reasonable interval fully informed regarding status communication with each regulatory authority promptly upon tillotts rsquo written request time after date continued development election been made shall transfer tillotts sponsorship regulatory filing made preparation licensed territory including limited those made with committee orphan medicinal product ldquo comp rdquo provided however that until such transfer completed shall consult regularly with tillotts keep tillotts informed advance material decision made document filed significant discussion scheduled with regulatory authority licensed territory with respect licensed field provide tillotts copy material correspondence with regulatory authority with respect such matter provided further tillotts shall have final decision making authority with respect such action described clause must reasonably support tillotts rsquo submission each with corresponding regulatory authority legally permitted tillotts designee shall holder corresponding approval licensed territory during term license agreement earlier terminated upon expiration license agreement thereafter upon approval corresponding regulatory authority tillotts must provide copy approved final dossier ectd format font font style font family time roman time serif font font style font size prosecuting each tillotts must exercise commercially reasonable effort maximize reimbursed price licensed product each dosage form which approval received this agreement terminated reason before expiration other than breach pursuant subsection termination breach immediate breach pursuant subsection then tillotts hereby irrevocably assigns upon effectiveness such termination tillotts rsquo right title interest held name tillotts provide letter authority reference other reasonable further assurance deem reasonably necessary desirable evidence vest perfect right cost recording such assignment transfer with applicable regulatory authority will borne tillotts this agreement terminated tillotts pursuant subsection unilateral termination extraordinary termination event terminated pursuant subsection termination breach immediate breach termination font style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection cooperation support prosecuting party must commercially reasonable diligence work together collaboratively good faith relating tillotts rsquo preparation filing each rsquo effort obtain marketing approval sell licensed formulation country outside licensed territory subject tillotts rsquo right under subsection section generally during term this agreement each party must make available other party without charge timely manner document filed with pertinent regulatory authority part scientific advice procedure before submission under this agreement must reasonably consider other party rsquo comment change request those document correspondence written communication with between party regulatory authority connection with conduct phase trial preparation submission drug application technical scientific clinical data result that owns control sense being able grant license right thereunder right disclose without breach obligation third party related administration licensed formulation that support approval regulatory approval regulatory approval commercialization that style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent upon giving advance written notice tillotts will have right reference incorporate otherwise approval obtained licensed formulation country outside licensed territory information data contained therein purpose related preparation filing support approval upon tillotts rsquo written request must promptly provide tillotts without charge document containing licensed information tillotts reasonably request from time time support preparation filing acceptance issuance approval including documentation referencing approval document filed with other corresponding governmental authority outside licensed territory subject tillotts sharing cost mutually agreed pursuant subsection additional study information data including clinical trial result data obtained from report regarding serious adverse event related administration licensed formulation clinical trial conducted outside licensed territory rsquo possession control which tillotts rsquo reasonable opinion necessary comply with obligation under applicable licensed territory with request regulatory authority other authority style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent upon giving advance written notice tillotts will have right reference incorporate otherwise approval information data contained therein information generated under initial development plan subsequent approved version thereof purpose related approval licensed formulation outside licensed territory inside licensed territory outside licensed field tillotts must promptly provide without charge those document information tillotts rsquo possession control that required applicable regulation that generated under initial development plan japanese development plan subject sharing cost mutually agreed pursuant subsection additional study country reasonably request from time time support preparation filing acceptance issuance application seek marketing approval sell licensed formulation medicinal therapeutic prophylactic purpose outside licensed territory country outside licensed field clinical other data information tillotts rsquo possession control reasonably consider necessary complying with regulatory obligation relating licensed formulation field country outside licensed field field country outside licensed territory strike strike style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent promptly after effective date party must undertake negotiate agree upon safety data exchange agreement govern particular exchange data contemplated this subsection party rsquo respective obligation with respect handling that data under applicable including privacy party rsquo responsibility upon potential violation those party rsquo respective liability such violation that agreement place before date first filing with regulatory authority either party suspend sharing data required under this subsection unless until safety data exchange agreement between party place style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify furtherance each party rsquo right obligation under this subsection each party represented delegate choosing participate advice meeting with regulatory authority licensed territory requested party style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection development program other indicated disease party acknowledge that initial development plan directed licensed formulation treat primary indication disease although secondary indication disease comprises indicated disease decision commence clinical study directed obtaining approval licensed formulation licensed territory treat prevent secondary indication disease before issuance acceptance approval licensed formulation tillotts rsquo sole absolute discretion subject however subsection below tillotts rsquo obligation with regard conduct clinical study directed obtaining approval licensed formulation licensed territory treat prevent gastrointestinal disease added indicated disease pursuant subsection above will subject supplemental disease development plan agreed upon party accordance with either those subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify shall conduct finance study outside primary indication disease that required rsquo pediatric committee final approved pediatric investigation plan defined described rsquo pertinent rule regulation order obtain maintain approval primary indication disease event tillotts right terminate agreement accordance with section style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection additional study party obligated share cost conducting elective clinical study such example limitation clinical study commonly termed ldquo phase iiib study rdquo ldquo phase study rdquo study described clause subsection study other activity that party demonstrates other party rsquo reasonable satisfaction necessary qualify second source manufacture furtherance intent subsection right granted thereunder other study that other regulatory authority request condition obtaining regulatory reimbursement pricing approval licensed product collectively ldquo additional study rdquo either party wish conduct additional study described clause above deems necessary reasonable opinion purpose optimizing commercial development prospect licensed formulation additional study described clause above required other relevant authority that grant directly indirectly approval pricing reimbursement approval upon written request either party party must promptly commence good faith discussion inform each other regarding need purpose such study develop agree upon protocol govern such study party agree conduct such study neither party unreasonably withheld agreement then cost conducting that study will shared party manner extent they mutually determine cost additional study will included determination total development cost fund more than majority cost conducting that study data result from that study will deemed owned data tillotts fund majority cost conducting that study data result from study will deemed tillotts owned data tillotts equally contribute funding cost conducting that study then data result from that study will deemed jointly owned tillotts party initially elect fund than half cost conducting that study that party elect without additional cost charge time before commencement that study fund cost that study equally with other party avoidance doubt order able freely data from initial majority funding party other party share corresponding cost unless party agree otherwise style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection bridge financing total development cost notwithstanding intent party forth subsection above able fully fund total development cost timely basis total development cost exceed able fully fund that excess collectively ldquo development cost deficiency rdquo tillotts agrees amount equal development cost deficiency ldquo deficiency payment maximum amount contribute development cost deficiency complete development licensed formulation contemplated under this agreement rsquo inability fully fund share total development cost timely basis breach this agreement must refund tillotts deficiency payment following manner party determine pursuant subsection below style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent tillotts elect treat deficiency payment loan that will bear simple interest outstanding amount rate five percent annum from date deficiency payment were funded tillotts until those amount repaid will timely repay outstanding deficiency payment accrued unpaid interest thereon follows approval licensed formulation issued obtained then tillotts must credit amount deficiency payment then remaining unpaid plus accrued unpaid interest thereon against earned royalty milestone payable under this agreement single reporting period total amount earned royalty milestone that particular reporting period approves rsquo drug application directed licensed formulation primary indication filed tillotts with finally formally declared approvable after full review that then unpaid deficiency payment plus accrued unpaid interest thereon will added enhanced right assumption forth subsection repaid same manner provided subsection finally formally decline approve rsquo drug application directed licensed formulation primary indication filed tillotts with finally formally declared approvable after full review that then party shall agree payback scheme according market standard condition loan such type style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subject rsquo consent tillotts rsquo election tillotts elect sole discretion apply deficiency payment more than deficiency payment otherwise agreed purchase restricted stock accordance with term such purchase specified article below style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection reporting adverse drug experience during phase trial through date first filing licensed territory tillotts must report appropriate regulatory authority adverse drug experience from phase trial other clinical trial conducted directed licensed formulation accordance with appropriate regulation pertinent country this connection will make sure that corresponding investigator site contract entered into based phase trial include reference timely reporting adverse drug experience back such investigator site thereafter tillotts must report must cause affiliate sublicensees report adverse drug experience pertaining licensed formulation appropriate regulatory authority licensed territory accordance with appropriate regulation pertinent country promptly after constituted must develop thereafter periodically update warranted change applicable safety data exchange procedure governing party rsquo collection investigation reporting exchange information concerning adverse drug experience country manner that enables each party comply with legal obligation under applicable regarding reporting adverse drug experience style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection inspection right clinical trial site will advise tillotts ldquo cause rdquo audit inspection that intends conduct site licensed territory which clinical study under phase trial being conducted phrase ldquo cause rdquo refers audit inspection done response serious compliance with current good clinical practice defined applicable regulation directive guidance document tillotts request will allow tillotts designate representative that accompany rsquo inspection team will endeavour obtain such consent tillotts reasonably belief that clinical trial site conducting phase trial manner that violates applicable regulation then tillotts shall notify such belief including specific regulation that tillotts belief being violated fact information which tillotts base such belief initiate appropriate investigation within thirty after receiving such notice then upon reasonable good faith request tillotts investigation shall diligent effort conduct appropriate investigation with tillotts representative permit tillotts conduct such investigation each case subject obtaining necessary consent from applicable principal investigator institution provided however that tillotts make such request more than once calendar year site tillotts shall bear cost together with pocket cost incurred either tillotts course such investigation style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection diligence japan during period from effective date until tillotts make continued development election pursuant subsection tillotts shall upon rsquo reasonable request meet with periodically either through separately discus evaluate good faith plan development licensed formulation japan including indication other than primary indication disease thereafter tillotts make continued development election tillotts otherwise agreed shall diligent good faith effort promptly establish close consultation with overall plan developing obtaining approval licensed formulation sale japan primary indication ldquo japanese development plan rdquo otherwise agreed conduct applicable portion japanese development plan including clinical study deemed necessary tillotts schedule that consistent with being able begin promptly after application approval licensed formulation united state submitted such other date party mutually agree additional human clinical study that tillotts anticipates will necessary support approval japan date that such application approval licensed formulation united state accepted filing tillotts completed except reason beyond tillotts rsquo control otherwise agreed clinical study reasonably anticipated necessary order begin human clinical trial support approval japan primary indication disease such other indication mutually agreed then sole remedy such failure terminate tillotts rsquo right with respect japan immediately upon written notice tillotts request that assist performing japanese development plan tillotts rsquo cost amount mutually agreed style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style margin nbsp nbsp style font time roman time serif margin text align justify text indent section joint steering committee before date thirty after effective date this agreement party will form joint steering committee ldquo rdquo provide formalized structure examine advise decision forth subsection below that arise during conduct phase trial communication between party regarding initial development plan other strategic matter generally will also mean which party exchange information related conduct initial development plan each party must duly consider recommendation given good faith considering implementing recommendation majority member will retain right authority control conduct phase trial accordance with protocol except those matter expressly reserved tillotts pursuant section below additionally power authority responsibility amend modify this agreement waive party rsquo right obligation under this agreement determine cost revenue make expenditure pricing decision style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection constitution action will have member three designated each party otherwise agreed designee from each party must senior executive designating party with authority contractually bind that party ldquo senior representative rdquo designee from each party must expert scientific clinical matter relating phase trial remaining designee party must expert regulatory matter relating phase trial quot regulatory representative rdquo purpose preparing conducting meeting only voting breaking purpose regard recommendation made rsquo senior representative will serve chair ldquo chair rdquo each party will have right time during term reason designate replacement that party rsquo designee sending written notice member other party each party will bear cost including travel lodging food video teleconferencing cost their respective representative serving attending person meeting must consensus member each party will cause representative achieve consensus establish through committee comprised more member style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection meeting will first meet before date sixty after effective date thereafter will meet necessary than once every calendar quarter site such meeting will alternate between basel switzerland tucson arizona such other location agreed party first meeting will occur tucson arizona lieu person meeting meeting take place telephonic video conference other than with respect special meeting which called either party than five business prior written notice which notice mail chair must send member notice agenda each meeting least business before date that meeting promptly after each meeting chair must prepare distribute facsimile mail member draft minute including recommendation made action item identified meeting promptly after receipt approval draft minute chair must finalize sign minute circulate same member chair will keep custody minute other record proceeding style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection right withdraw from time during term reason withdraw from participation upon written notice tillotts which notice will effective immediately upon receipt quot withdrawal notice quot upon issuance withdrawal notice long withdrawn from representative participate meeting vote recommendation made time following issuance withdrawal notice wish resume participation must notify tillotts writing thereafter representative attend subsequent meeting participate activity vote recommendation made provided this section issued withdrawal notice following rsquo issuance withdrawal notice unless until resume participation provided above meeting will held tillotts rsquo facility tillotts rsquo representative alone vote recommendation made tillotts must provide note minute meeting will have right approve minute meeting held during time withdrawn from style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section decision making authority style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection generally except with regard excepted matter defined below tillotts will have final decision making right authority matter directed obtaining japan approval licensed formulation licensed field will have final decision making right authority matter directed obtaining licensed territory other than japan approval licensed formulation licensed field before date which tillotts make deemed make continued development election continued development election except those action decision mandated section tillotts will have final decision making right authority matter directed obtaining licensed territory approval licensed formulation licensed field before date which tillotts make deemed make continued development election continued development election party vested with final decision making authority with respect particular matter provided above must duly consult with other party take into account interest upon making final decision with respect particular matter within scope exclusive authority communicate that decision other party promptly style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection excepted matter notwithstanding recommendation committee inability reach consensus party otherwise unable agree course action following matter each ldquo excepted matter rdquo collectively ldquo excepted matter rdquo party having final decision making right authority with respect that matter exercise that right authority with respect style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent amendment modification protocol manner that change indicated disease that subject protocol ldquo excepted matter rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent termination suspension delay phase trial before completion accordance with protocol ldquo excepted matter rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent matter relating label licensed product change thereto ldquo excepted matter rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent amendment modification protocol manner that change more endpoint such materially delay filing with ldquo excepted matter rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify that event senior representative party will endeavor resolve difference view resolution reached before date thirty after date which could reach consensus such earlier date required regulatory authority ldquo resolution deadline rdquo excepted matter will resolved follows style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent excepted matter status shall maintained style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent excepted matter phase trial must terminated style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent order termination indefinite suspension phase trial reason related patient safety style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent come consensus regarding recommendation party terminate suspend delay phase trial regulatory representative each party must each appoint external scientific regulatory expert within after resolution deadline which external expert will together appoint third scientific regulatory expert within after both have been appointed three whom will together constitute serve expert advisory panel ldquo expert panel rdquo within thirty after resolution deadline party must each submit expert panel independent statement regarding point disagreement concerning termination suspension delay phase trial along with such reasonable supporting documentation either party wish provide expert panel will review each party rsquo statement will free engage inter partes parte communication with member expert panel deem desirable necessary inform itself regarding excepted matter status phase trial will maintained through date that expert panel render decision regarding excepted matter expert panel render decision excepted matter party must promptly abide decision expert panel each party responsible expense incurred appointee expert panel party rsquo must each expense third member expert panel promptly upon receipt that third member rsquo invoice expert panel will upon vote majority member expert panel style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent excepted matter tillotts make continued development election continued development election phase trial completed tillotts must promptly make final determination excepted matter style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify excepted matter status must maintained unless protocol must changed comply with recommendation mandate which case protocol will changed style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify thirty period forth above with regard determining resolution deadline will reduced five business case action which response decision mandated than thirty regulatory authority applicable style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section commercialization tillotts affiliate sublicensees must maintain record reasonably sufficient detail document reflect accurately effort required under this section which record will subject inspection pursuant subsection below style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection diligent effort tillotts primary indication disease style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small diligence obtaining pricing reimbursement approval font font style font variant small font approval licensed formulation primary indication disease received each country licensed territory tillotts must diligently seek file obtain pricing reimbursement approval each country within jurisdiction approval that before date three month after date which approval obtained tillotts must make necessary filing request pricing reimbursement approval each country within jurisdiction that approval seeking pricing reimbursement approval tillotts must exercise commercially reasonable diligence obtain that approval file necessary report respond reasonable request from pertinent regulatory authority exhaust administrative remedy reasonably available being understood that litigation other adversarial proceeding reasonably available remedy instance adverse action style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small diligence marketing selling licensed product font font style font variant small font approval licensed formulation primary indication disease received each country licensed territory pricing reimbursement approval required before marketing sale licensed product begin country given tillotts must exercise reasonable commercial diligence defined below sole expense advertise promote sale licensed product each such country satisfy demand that result from those effort sell licensed each such country exercise ldquo reasonable commercial diligence rdquo tillotts through affiliate must expend devote effort resource that would used company similar standing within pharmaceutical industry marketing promotion sale general commercialization product enjoying primacy among other product potential product tillotts affiliate licensed field fail after date which first reimbursement price licensed product approved licensed territory sell licensed product period sixty consecutive failure exercise reasonable commercial diligence material breach this agreement that later than date three month after date which tillotts receives approval licensed product country obtains pricing reimbursement approval required before marketing sale licensed product begin country tillotts must have made substantive progress assembling force sale marketing personnel licensed product that country educating that force about licensed product engaging distributor otherwise established distribution channel licensed product that country regard education their respective sale marketing force each party must provide reasonable assistance other party other party rsquo sole expense sharing sale marketing know otherwise educating other party rsquo sale marketing force upon rsquo written request tillotts must provide with electronic copy sale promotional advertising material representative sale marketing effort licensed product those country style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small diligence post marketing matter font font style font variant small font promptly after receiving approval licensed product country tillotts must have made substantive progress establishing network system ensure regulatory compliance facilitate regulatory communication including timely reporting investigation adverse event reported connection with administration licensed product patient handle inquiry complaint about licensed product support return recall withdrawal licensed product that country tillotts must make regulatory report communicate with each regulatory authority regarding reportable adverse event must provide each every adverse event report concurrently with providing each such report regulatory authority likewise must make regulatory report communicate with each regulatory authority regarding reportable adverse event arising from rsquo sale licensed formulation primary indication outside licensed territory must provide tillotts each every adverse event report concurrently with proving each such report regulatory authority shall create maintain global safety database tillotts shall provide safety related data timely manner that permit comply with applicable regulation style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection tillotts development effort secondary indication disease style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small reserved right font font style font variant small font notwithstanding other provision this agreement contrary expense close consultation with tillotts develop licensed formulation secondary indication disease licensed territory until tillotts exercise secondary disease election defined below provided however that shall have right offer sell sell licensed formulation secondary indication licensed territory except expressly permitted under section style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small secondary disease interim election font upon earlier date that ninety after receiving interim analysis report defined section from phase trial primary disease indication completion formulation licensed formulation secondary indication disease such date ldquo secondary disease interim election date rdquo tillotts either prepare deliver before date ninety after secondary disease development election date reasonable plan acceptable such acceptance unreasonably withheld further diligent development application approval licensed territory licensed formulation treatment secondary indication disease time frame under which that plan will commence implemented conducted tillotts expense agree such plan timeline proposed either such plan ldquo secondary disease development plan rdquo before date ninety after secondary disease development election date party agree upon final formal secondary disease development plan then continue develop licensed formulation secondary indication disease secondary disease development plan mutually agreed then tillotts must exercise reasonable diligence sole expense implement conduct secondary disease development plan obtain approval licensed formulation treat prevent secondary indication disease style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small secondary disease final election font before date that ninety after tillotts receives final report from phase trial primary disease indication ldquo secondary disease final election date rdquo tillotts must provide written notice that tillotts shall either continue perform already agreed secondary disease development plan that agreed will perform secondary disease development plan forth above ldquo secondary disease ldquo rdquo notice rdquo cease work under already agreed secondary disease development plan transfer right secondary indication disease back ldquo secondary disease ldquo rdquo notice rdquo tillotts delivers secondary disease notice developed licensed formulation secondary indication disease during term this agreement rsquo cost then tillotts shall within thirty after delivery secondary disease notice reimburse development cost incurred during such period that otherwise incurred under initial development plan reasonably documented plus mark either twenty percent tillotts agreed began performing secondary disease development plan before ninety after secondary disease interim election date mark fifty percent tillotts agreed began performing secondary disease development plan thereafter provided however that cost such clinical trial used registration both europe united state will reimbursed fifty percent such amount tillotts deliver timely secondary disease notice tillotts delivers secondary disease notice then effective secondary disease final election date secondary indication disease shall automatically excluded from licensed field sole discretion develop commercialize licensed formulation secondary indication disease licensed territory tillotts shall promptly transfer assign data information regulatory approval owned controlled tillotts that were generated under secondary disease development plan provided however that rsquo licensed formulation interchangeable formulation then rsquo sale secondary indication disease licensed territory shall subject payment tillotts royalty such sale other mutually agreed compensation which each party rsquo senior management shall negotiate good faith order compensate tillotts reasonably anticipated lost sale caused rsquo sale interchangeable formulation secondary indication disease licensed territory party reach such agreement within ninety after secondary disease final election date then either party written notice other party require that such royalty rate other compensation determined valuation expert panel accordance with section whose decision shall final binding party style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection supply licensed product style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small exclusive sourcing font font style font variant small font except party otherwise agree tillotts must source licensed product commercial sale exclusively through must make sure that source have been validly established order able timely fulfill tillotts rsquo corresponding commercial order tillotts make continued development election promptly thereafter party must commence negotiation directed pharmaceutical supply agreement which will timely supply licensed product form mutually agreed tillotts sublicensees sufficient quantity sale ldquo supply agreement rdquo price mutually agreed specified therein ldquo transfer price rdquo supply agreement will also specify rsquo warranty timely supply licensed product tillotts sublicensees sufficient quantity sale under this agreement well other customary term condition supply licensed product rsquo sourcing licensed formulation tillotts under supply agreement constitute exhaustion right under licensed patent light foregoing tillotts must nonetheless earned royalty accordance with this agreement sale licensed product containing licensed formulation sourced through style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small tillotts right manufacture after expiration exclusive sourcing font font style font variant small font party acknowledge agree that effective date subject legally binding obligation regarding exclusivity current source compound licensed formulation promptly after such exclusivity obligation party will negotiate amendment this agreement include right tillotts make have made licensed formulation such represent warrant that tillotts obtain qualify second source compound licensed formulation time before expiration exclusivity period referred above nonetheless promptly after effective date party will approach cpps supplier endeavor obtain supplier rsquo agreement modify exclusivity granted that supplier under agreement with permit tillotts develop qualify second source compound licensed formulation subject such condition supplier require anticipation that possibility party must incorporate into initial development plan then current version thereof task timeline identifying obtaining qualifying second source compound licensed formulation circumstance which rsquo current supplier agrees modify exclusivity contemplated above which style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection trademark determination upon request either party party must confer consult with each other regarding trademark service mark other branding licensed territory collectively ldquo mark rdquo that will used commercialization marketing other promotion licensed product which filing approval licensed territory been made provided that tillotts make final decision with respect mark licensed territory during term tillotts will right title interest applicable mark licensed territory goodwill tillotts rsquo business which mark used which symbolized mark which avoidance doubt include ownership right interest licensed patent licensed information improvement licensed territory will right title interest applicable mark country outside licensed territory goodwill rsquo business which mark used which symbolized mark country outside licensed territory sole expense tillotts must file application register country licensed territory mark agreed upon party upon normal expiration this agreement tillotts rsquo ownership mark licensed territory corresponding goodwill described above will irrevocably permanently vest tillotts this agreement terminated before normal expiration reason other than rsquo breach this agreement then tillotts hereby irrevocably assigns upon such termination right title interest applicable mark licensed territory goodwill tillotts rsquo business which mark used which symbolized mark tillotts must execute deliver document further assurance reasonably request confirm evidence perfect assignment those mark goodwill right will have right obligation file application register mark country outside licensed territory sole expense style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align center article style font time roman time serif margin text align center financial term style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section license issue before date thirty after effective date consideration part grant license hereunder delivery licensed information pursuant section tillotts must refundable creditable license issue eight million dollar ldquo issue rdquo respect right granted hereunder country licensed territory style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section development milestone payment tillotts must following amount time indicated below collectively ldquo development milestone payment rdquo individually generically ldquo development milestone payment rdquo facilitate tillotts rsquo internal processing each development milestone payment will issue invoice amount pertinent development milestone payment upon occurrence each event triggering development milestone payment payable thirty style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection first interim development milestone payment provided that reach first enrollment threshold defined below before date after first enrollment date excluding delay outside rsquo control ldquo first enrollment target date rdquo tillotts must ldquo first interim development milestone payment rdquo before date thirty after date which total number patient enrolled phase trial least total enrollment target ldquo first enrollment threshold rdquo achieves first enrollment threshold after first enrollment target date then tillotts shall first interim development milestone payment before date that sixty after date that achieves first enrollment threshold style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent font style font size subsection second interim development milestone payment provided that reach second enrollment threshold defined below before date after first enrollment date excluding delay outside rsquo control ldquo second enrollment target date rdquo tillotts must ldquo second interim development milestone payment rdquo before date thirty after date which total number patient enrolled phase trial least total enrollment target ldquo second enrollment threshold rdquo achieves second enrollment threshold after second enrollment target date then tillotts shall second interim development milestone payment before date that sixty after date that achieves second enrollment threshold font style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent font style font size subsection final development milestone payment provided that reach final enrollment threshold defined below before date after first enrollment date excluding delay outside rsquo control tillotts make made deemed have made continued development election ldquo final enrollment target date rdquo tillotts must final development milestone payment date that thirty after later date which total number patient enrolled phase trial equal exceeds total enrollment target date which tillotts make deemed have made continued development election ldquo final enrollment threshold rdquo with first enrollment threshold second enrollment threshold ldquo enrollment threshold rdquo singly referred generically ldquo enrollment threshold rdquo such amount equal difference ldquo final development milestone payment rdquo arrived subtracting from anticipated total development cost although resulting difference exceed font font style font size achieves final enrollment threshold after final enrollment target date then tillotts shall final development milestone payment before date that sixty after date that achieves final enrollment threshold date which tillotts make deemed have made continued development election before date ninety after total development cost finally determined pursuant subsection above final development milestone payment would have been computed based final determination total development cost must tillotts amount originally paid final development milestone payment that exceed recomputed final development milestone payment final development milestone payment would have been more computed based final determination total development cost tillotts must additional amount bring total tillotts paid final development milestone payment equal recomputed final development milestone payment which exceed event time final development milestone payment tillotts elect written notice delivered apply final development milestone payment purchase restricted stock accordance with article below tillotts provide written notice election apply portion final development milestone payment purchase restricted stock tillotts will deemed have waived right apply portion final development milestone payment decline sell tillotts restricted stock providing tillotts before date business after rsquo receipt tillotts rsquo election written notice that decline sell tillotts restricted stock timely decline sell restricted stock tillotts will deemed have accepted tillotts rsquo election purchase restricted stock decline sell restricted stock tillotts then final development milestone payment will reduced amount specified tillotts rsquo election purchase restricted stock example clarify sequence event final development milestone payment tillotts wish purchase restricted stock then date final development milestone payment tillotts will provide written notice that wish purchase restricted stock timely decline sell such restricted stock tillotts then will sell such restricted stock tillotts tillotts will such restricted stock each case forth stock purchase agreement that party will execute pursuant article later than thirty after date becomes obligated sell such restricted stock font style font time roman time serif margin text align justify text indent style font time roman time serif margin text align justify text indent field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection deficiency payment soon practicable after determines that there will development cost deficiency under subsection above must preliminarily estimate total development cost deficiency provide tillotts that preliminary estimate writing accompanied reasonably detailed analysis leading that estimate reasonable supporting documentation before date business after tillotts rsquo receipt that written preliminary estimate party will convene meeting arrive final estimate development cost deficiency timing manner tillotts rsquo making deficiency payment extent tillotts elect apply deficiency payment toward purchase restricted stock provided under subsection above will have obligation repay deficiency payment style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent section milestone tillotts must following amount time indicated below collectively ldquo milestone rdquo individually generically ldquo milestone rdquo facilitate tillotts rsquo internal processing payment each milestone will issue invoice amount pertinent milestone upon occurrence each event triggering payment which will have payment term consistent with those forth this section milestone neither refundable creditable against other amount under this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection milestone tillotts must before date thirty after date approval primary indication disease each country before date thirty after earliest occur that country following date first commercial sale that country date which applicable regulatory authority that country first approves pricing reimbursement schedule licensed product avoidance doubt maximum amount payable under clause above equal which amount that would payable first commercial sale approval pricing reimbursement schedule occurs country style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection japan milestone tillotts must before date thirty after date which applicable regulatory authority japan granted given licensed formulation treatment primary indication disease orphan drug designation status before date thirty after date which pertinent clinical trial report phase phase phase clinical trial conducted japan with respect licensed formulation primary indication disease indicates that primary point have been achieved before date thirty after date pmda rsquo first acceptance licensed formulation treat prevent primary indication disease before date thirty after date first commercial sale japan style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section continued development tillotts make deemed make continued development election under subsection above tillotts must ldquo continued development rdquo before date thirty after date which tillotts make deemed make continued development election continued development neither refundable creditable against other amount under this agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section earned royalty style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection amount accrual payment consideration part license right granted under article tillotts must during royalty term refundable earned royalty each licensed product sold tillotts sublicensee affiliate tillotts sublicensee including licensed product made during term this agreement sold after term this agreement amount earned royalty payable under this agreement equal applicable royalty rate time sale value licensed product applicable royalty rate given calendar year will vary depending amount total annual sale value royalty rate applicable increment total annual sale value will determined reference following table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width border bottom black solid font style font family time roman time serif total annual sale value expressed dollar font style width text align justify nbsp style width border bottom black solid text align justify font style font family time roman time serif royalty rate applicable total annual font font style font family time roman time serif sale value corresponding increment font style vertical align font style font family time roman time serif font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align font style font family time roman time serif greater than more than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align font style font family time roman time serif greater than more than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align font style font family time roman time serif greater than more than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align font style font family time roman time serif greater than more than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align font style font family time roman time serif greater than more than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align font style font family time roman time serif greater than font style text align justify nbsp style text align justify font style font family time roman time serif font table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify font style font size example font style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify only earned royalty will accrue paid particular individual licensed product even sold transferred between tillotts related party subsequent resale even manufacture that licensed product country covered licensed patent sale importation another country also covered licensed patent style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection earned royalty rate party have negotiated earned royalty rate their foregoing application mutual convenience party result disparity negotiating strength party foregoing should finally adjudicated impermissible then earned royalty rate forth above will deemed amended apply manner that account basis which product qualifies such that yield that same economic result before such amendment style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection royalty rate reduction style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small font font style font variant small absence exclusivity font there neither valid patent claim regulatory based exclusivity including orphan data pediatric exclusivity licensed product country within licensed territory royalty rate forth section shall automatically reduced pertinent royalty rate style font time roman time serif margin text align justify font style font variant small nbsp font style font time roman time serif margin text align justify text indent font style font family time roman time serif font font style font variant small competitive disadvantage font pertinent earned royalty rate given country country licensed territory where disadvantageous market condition defined below present shall reduced indicated this section such reduction earned royalty rate must event limited sale type licensed product country time which disadvantageous market condition defined below exist such that time those disadvantageous market condition begin cease apply earned royalty rate must reduced returned those forth subsection above first month immediately following month which those condition begin cease style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify ldquo disadvantageous market condition rdquo mean achievement commercialization directly competing product indirectly competing product third party that related party tillotts style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify ldquo directly competing product rdquo mean product that either approved respective national regulatory authority labeled prevent treat primary indication disease with such approval based primary endpoint comparable those licensed product including main primary endpoint delaying related surgical event generic product approved pertinent national authority under directive article comparable national regulation licensed product meaning that such generic product contains same active ingredient bioequivalent such licensed product provided however that such product registered primarily used adjunct therapy licensed product licensed formulation including interchangeable formulation which obtained that commercialized behalf licensee within licensed territory outside licensed field accordance with section right first negotiation field outside licensed field being understood that sole basis royalty reduction connection with such activity behalf licensee forth subsection distinct interchangeable formulation pediatric cancer style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify ldquo indirectly competing product rdquo mean product other than directly competing product that approved licensed territory indication being primary indication disease containing compound sulindac active ingredient dosage compound sulindac frac whole number multiple such provided however that such product licensed formulation including interchangeable formulation which obtained that commercialized behalf licensee within licensed territory outside licensed field accordance with section right first negotiation field outside licensed field being understood that sole basis royalty reduction connection with such activity behalf licensee forth subsection distinct interchangeable formulation pediatric cancer style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify total annual sale value attributable sale licensed product country affected will continue used calculation royalty threshold above determining applicable earned royalty rate reduction royalty rate shall follows style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify directly competing product style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify table cellspacing cellpadding style font time roman time serif width border collapse collapse margin left style vertical align style width border bottom black solid text align justify font style font family time roman time serif significant competition event font style width text align justify nbsp style width border bottom black solid text align justify font style font family time roman time serif reduction royalty rate font style vertical align style text align justify font style font family time roman time serif approval font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif product launch pricing reimbursement approval font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif product launch pricing reimbursement approval font style text align justify nbsp style text align justify font style font family time roman time serif font table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify tillotts belief that entitled royalty reduction under this subsection based directly competing product then tillotts shall provide prompt written notice such belief together with such information tillotts possession with respect timing amount such anticipated reduction such that make appropriate timely adjustment financial forecast information purpose additional pertinent documentation with next royalty rate calculation following date disadvantageous market condition began style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify indirectly competing product style font time roman time serif margin text align justify tillotts belief that entitled reduction royalty rate under this subsection then contrast information obligation regarding directly competing product tillotts shall provide written notice such belief together with relevant information tillotts rsquo possession control that related thereto ldquo disadvantageous market condition notice rdquo senior management each party shall meet promptly thereafter negotiate good faith agree whether what extent applicable royalty rate should reduced based this section party unable reach such agreement within sixty after delivery such disadvantageous market condition notice then either party written notice other party require that such determination made valuation expert panel constituted accordance with section whose decision shall final binding party provided that royalty reduction shall retroactive first month immediately following month which disadvantageous market condition notice began style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font family time roman time serif font font style font variant small elevated transfer price font adjustment specified this subsection well subsection will apply licensed product sourced under supply agreement reason based rsquo failure satisfy delivery requirement thereunder provided however that royalty have been reduced under this subsection more than consecutive quarter then tillotts shall diligent good faith effort shall support tillotts diligently good faith such effort obtain majority requirement licensed product from third party unless prohibited section supply licensed formulation exclusive sourcing unless transfer price proportion such third party supply royalty rate higher tillotts than before upon request either party party agree discus good faith adjustment this section based upon additional relevant information becomes available style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify ldquo transfer price proportion rdquo shall proportion transfer price paid licensed product sold respective quarter sale value achieved such quarter sale such licensed product licensed territory expressed percentage style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify transfer price proportion particular calendar quarter exceeds earned royalty rate under subsection that would otherwise applied sale value licensed product that sold during such calendar quarter will reduced amount equal half difference between applicable transfer price proportion provided however that event applicable earned royalty rate reduced below style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify example limitation transfer price proportion particular calendar quarter earned royalty rate first increment total annual sale value forth subsection above will reduced determined follows subtract from yielding difference then multiply half yielding product then subtract from yielding adjusted earned royalty rate that first increment total annual sale value style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify avoidance doubt total annual sale value attributable licensed product affected will continue used calculation royalty threshold above determining applicable earned royalty rate foregoing criterion transfer price proportion based anticipated economics primary indication disease licensed formulation receives approval licensed territory indication licensed field other than primary indication disease either party belief economics associated with such other indication such pricing licensed product cost material materially different than economics primary indication disease then party shall promptly discus good faith adjustment transfer price proportion order allocate between tillotts impact such change fair equitable manner style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small severe elevated transfer price font transfer price proportion three consecutive quarter exceeds then upon written request either party ldquo price discussion notice rdquo party must commence discussion before date forty five after date price discussion notice agree measure course action reduce transfer price proportion consequent necessary amendment commercial term this agreement before date ninety after date price discussion notice party agree those consequent necessary amendment tillotts elect sole discretion discontinue effort promote market licensed product required under subsection above although continue selling licensed product under this agreement tillotts postpone making sale milestone payment after expiration that ninety period until date which party agree consequent necessary amendment style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify reject sole absolute discretion amendment this agreement proposed tillotts that reduces applicable earned royalty rate below style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection challenge proceeding without prejudice right that have accrued under this agreement right remedy terminate this agreement immediately upon written notice tillotts tillotts affiliate sublicensee affiliate sublicensee commences brings country world challenge proceeding time during term this agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section sale milestone payment tillotts must sale milestone payment each ldquo sale milestone payment rdquo shown below total annual sale value reaching exceeding corresponding threshold amount shown below avoidance doubt each sale milestone payment single time payment paid first time which total annual sale value equal exceeds specified threshold level tillotts must sale milestone payment along with earned royalty report required under section fourth quarter calendar year which applicable total annual sale value threshold reached style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width border bottom black solid text align left vertical align bottom font style font family time roman time serif total annual sale value expressed font font style font family time roman time serif dollar font style width text align justify nbsp style width border bottom black solid text align justify font style font family time roman time serif sale milestone payment font font style font family time roman time serif corresponding milestone level expressed font font style font family time roman time serif dollar font style vertical align style text align justify font style font family time roman time serif greater than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif greater than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif greater than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif greater than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif greater than font style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif greater than font style text align justify nbsp style text align justify font style font family time roman time serif font table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify example style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section periodic report payment book record style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection frequency report before february august october each calendar year during term this agreement tillotts must deliver true complete written report showing item specified subsection below they pertain tillotts rsquo sublicensees rsquo activity under this agreement calendar quarter just ended responsible financial officer tillotts authorized designee tillotts rsquo independent accounting firm head tillotts rsquo internal audit committee must certify writing that each report delivered under this subsection correct complete tillotts rsquo payment earned royalty based activity calendar quarter covered each written report must wired rsquo account accordance with section before date that three after date which report earned royalty tillotts must report tillotts must require each sublicensee make appropriate report payment tillotts enable comply with this subsection determining sale value purpose calculating earned royalty payable hereunder tillotts applies discount billing based estimated discount contra revenue item those estimate must reconciled amount actually realized applied such reconciliation must reflected report made immediately after reconciliation made which event tillotts will apply credit against earned royalty that subsequent report earlier overpayment determined result reconciliation tillotts must addition earned royalty shown subsequent report earlier underpayment earned royalty sale milestone payment determined result reconciliation style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection report after expiration termination after expiration this agreement particular country with respect particular licensed product tillotts must continue provide quarterly report under this section activity that country with regard that licensed product long tillotts sublicensee sell licensed product before expiration this agreement which report will accompanied payment earned royalty based activity that subject those report notwithstanding obligation cease activity under this agreement upon termination this agreement pursuant section below tillotts sublicensee sell licensed product after termination this agreement tillotts must provide report with respect those unauthorized activity that complies respect with this section which report will accompanied payment earned royalty based activity that subject those report determined three time earned royalty rate specified section above tillotts must require each sublicensee make appropriate report payment tillotts enable comply with this subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection content quarterly report each report under this section must provide following information pertains preceding calendar quarter just ended style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent quantity licensed product billed tillotts sublicensees affiliate tillotts sublicensees each country licensed territory separately stated each reporting entity each country selling entity style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent dollar value billing such quantity above style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent computation sale value based dollar value determined above including detailed accounting item item basis allowed deduction from contra revenue item applied invoice amount arrive sale value style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent computation total annual sale value calendar year which fall calendar quarter that subject report which computation will include sale value computed under clause above style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent determination earned royalty rate under section above applicable total annual sale value reported pursuant clause above style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent computation earned royalty based sale value computed under clause above earned royalty rate determined under clause above style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent computation credit against earned royalty permitted under subsection above style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent total amount earned royalty paid with respect accounting period that subject that report style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection book record tillotts must keep complete accurate book accordance with local reasonable supporting documentation determine accuracy item reported under this section compliance other respect with obligation under this agreement tillotts must keep those book documentation principal place business five year following calendar year which they pertain access those book which denied tillotts independent auditor nominated reasonably acceptable tillotts thereafter they reasonably available once calendar year during tillotts rsquo normal business hour such independent auditor audit inspect those book documentation verify accuracy content tillotts rsquo quarterly report earned royalty statement report result that audit inspection must provide tillotts with thirty business written notice before conduct audit inspection audit inspection discloses underpayment earned royalty lesser more amount earned royalty actually reporting period hundred fifty thousand dollar then tillotts must reasonable cost that audit inspection before date thirty after receipt bill invoice such audit inspection from tillotts must require that sublicensees keep book documentation same type same format enable tillotts comply with obligation under this section tillotts dispute result audit inspection party otherwise able come agreement adjustment corresponding financial matter within sixty after date independent auditor rsquo report then party will submit matter dispute resolution proceeding section style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section invoicing payment procedure based rsquo properly issued invoice tillotts must amount under this agreement united state currency collectible without deduction wire transfer style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text align justify font style font family time roman time serif account font style width text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif beneficiary bank font style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif address font style text align justify font style font family time roman time serif font style vertical align style text align justify nbsp style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif phone number font style text align justify font style font family time roman time serif font style vertical align style text align justify font style font family time roman time serif routing number font style text align justify font style font family time roman time serif font style vertical align nowrap style text align justify font style font family time roman time serif customer account number nbsp font style text align justify font style font family time roman time serif font style vertical align font style font family time roman time serif swift code font font style font family time roman time serif font table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify account such other bank from time time designate writing avoidance doubt tillotts must cost wire transfer amount than tillotts elect company check instead wire transfer rsquo notice address provided below style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section late payment tillotts fails make payment required under this agreement before date after receipt written notice tillotts rsquo failure timely undisputedly under this agreement tillotts must simple interest unpaid amount rate equal month which interest will accrue from date unpaid amount became until date unpaid amount paid full that interest rate exceeds rate allowed applicable then highest interest rate allowed will apply must apply payment received first satisfaction unpaid accrued interest then satisfaction unpaid principal style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section tillotts must bear charge other than based rsquo income assessed imposed governmental authority excluding withholding collectively ldquo deductible rdquo payment under this agreement under existence effective date event that after effective date imposing deductible payment under this agreement either amended newly imposed party then party shall discus good faith equitable allocation responsibility such deductible based relevant fact circumstance tillotts must make payment under this agreement undiminished deductible payment tillotts under this agreement must originate from switzerland style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent withholding tillotts required under applicable regulation government order withhold amount payable tillotts licensor under this agreement tillotts shall withhold over appropriate governmental authority such licensor shall accept payment such full satisfaction tillotts rsquo obligation make such payment tillotts shall obtain furnish licensor within thirty such payment official receipt other evidence payment such sufficient permit licensor establish right exemption from credit such against liability refund available withholding other paid payable tillotts event that governmental authority requires licensor provide additional information record establish right such credit exemption refund tillotts shall fully promptly cooperate with licensor provide licensor within thirty licensor rsquo request such additional information record licensor request tillotts shall provide licensor with such assistance documentation licensor shall request connection with application licensor qualify benefit reduced rate withholding taxation under term applicable treaty tillotts shall solely liable shall indemnify hold licensor affiliate harmless against penalty interest expense incurred assessed against licensor affiliate result tillotts rsquo failure withhold such timely remit them appropriate taxing authority event that licensor required refund tillotts amount paid hereunder pursuant term condition this agreement licensor shall required refund that portion those amount which were withheld tillotts order comply with applicable unless until licensor receives refund such amount from applicable governmental authority style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section tillotts audit right independent auditor nominated tillotts reasonably acceptable inspect rsquo book pertaining following matter collectively ldquo tillotts audit matter rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent rsquo final determination total development cost pursuant subsection corresponding determination development cost deficiency pursuant subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent rsquo final determination amount development termination under subsection determination corresponding wind down expense style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent rsquo report total annual sale value licensed formulation united state america given year used determine amount earned royalty payment under subsection payment under subsection right assumption subsection enhanced right assumption amount specified subsection that payable manner forth subsection addition enhanced right assumption style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent such other record reasonably necessary mutually agreed good faith related rsquo payment obligation under this agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify must keep complete accurate book accordance with local reasonable supporting documentation determine accuracy tillotts audit matter must keep those book documentation principal place business five year following calendar year which they pertain except that case tillotts audit matter described clause above earlier dispose those book documentation upon completion tillotts rsquo inspection deny tillotts rsquo independent auditor access those book thereafter they reasonably available tillotts conduct such inspection only once calendar year after rsquo annual corporate audit other than cause during rsquo normal business hour tillotts must provide with thirty business written notice before tillotts conduct inspection inspection with respect tillotts audit matter described clause above discloses discrepancy resulting underpayment under subsection lesser five percent more amount payment actually entire time period that subject audit inspection hundred fifty thousand dollar then must reasonable cost that inspection before date thirty after receipt bill invoice such inspection from tillotts must require that licensee keep book documentation same type same format enable comply with obligation under this section inspection with respect tillotts audit matter described clause above discloses discrepancy between amount determined amount determined tillotts rsquo independent auditor case clause would result potential overpayment tillotts under subsection party otherwise able come agreement adjustment corresponding financial matter within sixty after date report tillotts rsquo independent auditor then party will submit matter dispute resolution proceeding section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align center article style font time roman time serif margin text align center data intellectual property right patent prosecution style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent section data style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection definition data ldquo data rdquo mean result information data including clinical data generated behalf party under this agreement result developing licensed formulation licensed field including accordance with initial development plan secondary disease development plan supplemental disease development plan including foregoing amended course obtaining maintaining approval licensed product style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ownership data style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font family time roman time serif font font style font variant small owned data font except otherwise mutually agreed writing accordance with subsection additional study with respect additional study partially funded reimbursed either tillotts party shall data generated under this agreement third party behalf ldquo owned data rdquo including such data generated arising from phase trial primary indication disease data generated rsquo development licensed formulation secondary indication disease accordance with section clarity owned data shall automatically included without payment additional consideration tillotts within definition licensed information shall made available tillotts repository accordance with section delivery avoidance doubt this mean that subject term condition this agreement tillotts such owned data purpose licensed territory licensed field such owned data outside licensed territory outside licensed field within licensed territory outside licensed field tillotts shall owned data outside licensed territory within licensed territory outside licensed field shall owned data within licensed territory within licensed field style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small tillotts owned data font except otherwise mutually agreed writing accordance with subsection additional study with respect additional study partially funded reimbursed either tillotts tillotts shall solely data generated tillotts third party behalf tillotts ldquo tillotts owned data rdquo including such data generated arising from secondary disease development plan supplemental disease development plan japanese development plan course tillotts rsquo effort obtain approval licensed product licensed field style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small jointly owned development data font party share equally cost additional study accordance with subsection then unless otherwise agreed writing each tillotts shall undivided half share data generated such additional study ldquo jointly owned data rdquo unless otherwise agreed writing each party shall have unrestricted right disclose such jointly owned data purpose style font time roman time serif margin text align justify nbsp nbsp style font time roman time serif margin text align justify text indent section intellectual property right style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection background licensed patent licensed information time will remain owned controlled except otherwise provided under this agreement party acquires right intellectual property right apart from those licensed granted under this agreement that pertain development commercialization licensed formulation those intellectual property right will owned controlled that party designee time each party must immediately inform other party that circumstance whereupon party will promptly convene meeting advise party regarding extent which those intellectual property right should made subject this agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection development style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small general font intellectual property right that arise from party rsquo activity performing obligation exercising right under this agreement tillotts rsquo activity before effective date solely extent based using information that effective date became licensed information collectively ldquo development rdquo shall owned forth forth this section style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small owned development font shall development other than tillotts owned development defined below ldquo owned development rdquo including development that relates licensed formulation outside licensed field development that conceived reduced practice patentable discovered created patentable solely clarity notwithstanding joint ownership owned data generated phase trial between party shall solely intellectual property right that conceived reduced practice conduct phase trial provided that such intellectual property right would automatically become either licensed patent licensed information applicable without further payment tillotts tillotts hereby assigns tillotts rsquo right title interest owned development upon rsquo request expense tillotts shall execute such document deems necessary useful perfect record such assignment partial consideration obtaining right tillotts owned development under subsection license grant patentable owned development shall automatically included within definition licensed patent patentable owned development shall automatically included within definition licensed information each case without payment additional consideration tillotts style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small tillotts owned development font tillotts shall development that conceived reduced practice patentable discovered created patentable solely tillotts affiliate tillotts directly relates licensed formulation licensed field including improved formulation licensed formulation licensed formulation treat disease within licensed field collectively ldquo tillotts owned development rdquo style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section license grant partial consideration tillotts obtaining right owned development without paying additional compensation tillotts hereby grant royalty free fully paid perpetual irrevocable license with right grant sublicenses under tillotts owned data including tillotts owned data generated from additional study that partly funded least fifty percent cost excluding tillotts owned data generated from additional study which tillotts paid fifty percent more cost unless otherwise agreed writing tillotts owned development including tillotts patent right defined subsection follows style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent outside licensed territory such license exclusive license even tillotts purpose including make sell offer sell import product that would licensed product sold tillotts licensed territory including licensed formulation style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent within licensed territory solely follows exclusive license solely extent right under subsection tillotts development effort secondary indication disease develop sell licensed formulation within licensed territory terminates this agreement accordance with subsection breach tillotts subsection financial default tillotts then exclusive license practice purpose including make sell offer sell import product that would licensed product sold tillotts licensed territory before termination this agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section misellaneous style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection disclosure development promptly after discovery creation invention development made authorized representative each party must expend such resource reasonably necessary prepare sign document ldquo disclosure rdquo that provides full complete reasonably detailed written description development including procedure data know other technical information relating thereto preliminary determination whether development owned development tillotts owned development each disclosure must made available repository agree preliminary determination type development required under clause immediately preceding sentence then party will submit matter dispute resolution procedure section before date thirty after termination this agreement each party must provide list development right disclosure regarding each previously subject disclosure style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection inventorship otherwise agreed case case basis inventorship each development right will determined accordance with patent united state american governing determination inventorship regardless patent that apply jurisdiction where such improvement conceived reduced practice enable each party comply with obligation under this section each party represents warrant other party that each representative representing party under written obligation which that representative assigns representing party right title interest each every improvement corresponding intellectual property right avoidance doubt invention made know information developed generated party representative that development right subject this section style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection cooperation prosecution patent right upon written request party with right authority under subsection file prosecute patent application that development ldquo authorized party rdquo other party representative must cooperate with authorized party prosecution patent application claiming development authorized party must promptly reimburse other party reasonable expense incurred connection with providing such assistance authorized party represent warrant other party that patent will issue granted based patent application that development that patent issuing thereon valid enforceable upon other party rsquo reasonable request occurring more frequently than monthly authorized party will apprise other party status patent prosecution patent application that development authorized party will responsible error omission patent counsel chosen authorized party style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section prosecution style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection generally must continue diligently prosecute maintain patent application comprising licensed patent good faith sole expense using patent counsel choosing tillotts must diligently prosecute maintain patent application claiming tillotts owned development ldquo tillotts patent right rdquo clarity authorized party with respect licensed patent tillotts authorized party with respect tillotts patent right subject obligation consult with authorized party regarding prosecution abandonment each licensed patent provided below authorized party obligation final decision making authority directing paying filing prosecution maintenance licensed patent case tillotts patent right case tillotts making election payment connection therewith including whether which country seek patent protection avoidance doubt event that authorized party wish seek broader patent protection than authorized party authorized shall have right expense seek such broader protection country which exclusive license under this agreement provided that such action reasonable good faith judgment authorized party after consultation with authorized party conflict with authorized party rsquo patent strategy territory where authorized party retains right authorized party rsquo patent outside such territory risk being found invalid unenforceable authorized party shall carry administrative action this regard reasonably necessary permit authorized party exercise such right error omission patent counsel chosen authorized party shall considered material breach this agreement however authorized party shall reasonably pursue remedy recover damage damage awarded will equally divided party event that authorized party wish pursue such remedy authorized party shall have right pursue remedy shall able keep damage awarded account style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection font style font family time roman time serif comment authorized party font authorized party will exercise commercially reasonable effort solicit authorized party rsquo comment filing made with patent authority country regarding licensed patent case tillotts patent right case tillotts sufficiently advance date that filing afford authorized party reasonable opportunity consider comment that filing authorized party must give consideration comment provided authorized party upon authorized party rsquo reasonable request occurring more frequently than monthly authorized party will apprise authorized party status patent prosecution patent application comprising licensed patent case tillotts patent right case tillotts style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection abandonment licensed patent authorized party sole discretion abandon licensed patent case tillotts patent right case tillotts authorized party intends elect abandon patent patent application then such authorized party shall advise authorized party give authorized party opportunity continue such prosecution maintenance name authorized party authorized party rsquo expense authorized party will have liability subject claim damage inadvertently unintentionally abandon patent application patent fails seek extension licensed patent style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section patent term extension term restoration tillotts must reasonably cooperate with seeking available extension restoration term licensed patent tillotts rsquo cooperation includes supplying with information right file that information with regulatory authority reasonably requested that tillotts rsquo possession control that reasonably considers pertain desirable extension restoration term licensed patent must commercially reasonable effort provide timely manner with supporting affidavit document that requested required connection with such term extension term restoration avoidance doubt event that tillotts wish seek term extension term restoration after tillotts shall have right expense seek such extension restoration provided that tillotts prejudice rsquo right licensed patent other patent case shall carry administrative action this regard reasonably necessary permit tillotts exercise such right sole discretion elect seek extend term licensed patent without limiting generality foregoing tillotts must commercially reasonable effort advise timely manner approval with respect licensed product other governmental approval reasonably requested that pertinent extension restoration patent term licensed patent execute deliver timely manner authorization supporting affidavit other document reasonably requested connection with extension licensed patent take such other action reasonably requested obtain extension restoration tillotts must require affiliate sublicensee comply with this section extent country within licensed territory permit extension multiple patent covering licensed product tillotts wish seek extension more patent within tillotts patent right will have same obligation also right with respect tillotts patent right tillotts under this section with respect licensed patent style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align center article style font time roman time serif margin text align center infringement misappropriation style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font size section action party upon knowledge infringement misappropriation purpose this article term tillotts understood refer tillotts affiliate that tillotts appointed behalf certain part licensed territory accordance with subsection right power sublicense specifically regard tillotts rsquo affiliate each tillotts must promptly inform other writing either learns that third party infringing suspected infringing licensed territory licensed patent patent within tillotts patent right including limited through marketing sale licensed formulation misappropriated suspected misappropriating licensed information licensed territory brought proceeding alleging invalidity infringement licensed patent tillotts patent right font font style font size filed with regulatory authority foreign equivalent abbreviated drug application product that infringes patent claim tillotts patent right incorporated reference licensed information such filing activity suspected activity third party described immediately preceding sentence called ldquo infringing activity rdquo third party which foregoing pertains called ldquo infringer rdquo soon possible thereafter party must convene meeting either person other teleconference videoconference which party with knowledge infringing activity must present prima facie evidence infringing activity infringer evidence need form written opinion from party outside legal counsel that activity infringer constitute prima facie case infringement licensed patent tillotts patent right which opinion reasonably acceptable other party evidence acceptable other party party will discus available evidence infringing activity manner addressing infringing activity preserving right past future damage caused infringing activity meeting party will endeavor designate party responsible taking such action payment sharing cost addressing infringing activity legal representation sharing award other matter reasonably desirable address matter hand party agree pursue matter jointly appoint responsible party foregoing agreement party will reflected joint defense agreement protecting privileged status confidentiality party rsquo communication respect those infringing activity tillotts fail reach agreement within sixty after date which foregoing meeting first held provision section through inclusive control font style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section rsquo right party recognize agree that between party sole right infringement licensed patent that right necessarily extend tillotts except extent expressly granted this agreement duty pursue infringers exclusive right first instance obligation prosecute name infringement licensed patent misappropriation licensed information defend proceeding alleging invalidity infringement licensed patent initiate conduct legal proceeding enjoin seek damage caused infringing activity other relief remedy response infringing activity tillotts must fully cooperate with that effort including joining party proceeding required applicable bring maintain such action tillotts join such proceeding through counsel expense although will have sole control over those proceeding event that country licensed territory certain very short deadline have kept order prosecute infringer party shall enter into accelerated convening process order before expiration such short deadline order lose procedural right party have that respective country purpose additionally securing procedural right owner licensed patent shall issue letter authorization tillotts form mutually agreed which shall held escrow tillotts that reconvening with possible order before expiration such short deadline tillotts good faith against such infringer tillotts take action pursuant authority under such letter then tillotts shall notify writing such action soon possible event later than after such action including such notice detailed description fact legal requirement action taken together with copy correspondence with third party legal filing with respect tillotts patent right extent permissible under applicable country issuing such tillotts patent right will have same right obligation with respect tillotts patent right tillotts under this section with respect licensed patent style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section tillotts right style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection event requiring proceeding brought meeting described section addition letter authorization described section either party present prima facie evidence infringing activity infringer that reasonably acceptable other party case activity described clause section either evidence indicating that such infringement involves significant quantity defined below infringing product reasoned explanation such infringing activity sufficient strategic concern merit response even they involve significant quantity caused infringing activity terminate initiated legal proceeding which include lawsuit settlement discussion mediation arbitration against infringer based infringing activity before date after date section meeting then tillotts right obligation notify infringer that activity constitute infringement patent claim misappropriation licensed information that infringement misappropriation must cease prosecute name infringement action licensed patent defend action attacking validity enforceability scope licensed patent infringement type that under applicable regulation requires commence proceeding than period referred above will reduced half period specified applicable regulation party agree that temporary restraining order equivalent required period will reduced business foregoing right granted tillotts preclude from exercising time right have assignee licensee licensed patent licensed information with respect tillotts patent right extent permissible under applicable country issuing such tillotts patent right will have same right obligation with respect tillotts patent right tillotts under this subsection with respect licensed patent style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection required evidence prima facie evidence show that infringing activity involves significant quantity evidence must reasonably probative demonstrating rsquo reasonable satisfaction that infringer rsquo level sale infringing product pertinent country licensed territory constitute significant quantity that those sale compete with tillotts rsquo sale licensed product that country reasonably probative evidence might include showing comparable detrimental effect tillotts rsquo sale licensed product which detriment reasonably attributable infringer rsquo infringing activity trustworthy evidence amount sale tillotts rsquo customer prospective customer tillotts must notify writing whether tillotts elect prosecute infringing activity defend action involving licensed patent licensed information suit brought defended tillotts under this section expressly subject section through inclusive during preparation pendency proceeding defended instituted tillotts under this section must reasonably cooperate with tillotts including joining party proceeding required applicable tillotts bring maintain such action except provided below tillotts will have sole control such proceeding must keep reasonably informed progress thereof ldquo significant quantity rdquo mean sale product infringer country immediately preceding month before date section meeting represent gross billing greater than total annual sale value licensed product sold tillotts affiliate sublicensees immediately preceding month period same country than equivalent currency pertinent country style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section university arizona join tillotts acknowledges that university arizona assignee licensed patent owner element licensed information exclusive licensee under licensed patent owner element licensed information necessary party suit legal proceeding brought tillotts concerning infringing activity that event request behalf itself university arizona tillotts legal counsel must represent university arizona tillotts expense consequent legal proceeding tillotts legal counsel unable represent either university arizona because conflict interest other bona fide reason university arizona case engage other competent legal counsel tillotts expense represent university arizona such suit legal proceeding either university arizona wish represented tillotts legal counsel reason other than conflict interest other bona fide reason either engage competent legal counsel choosing represent expense with respect tillotts patent right extent permissible under applicable country issuing such tillotts patent right will have same right obligation with respect such tillotts patent right tillotts under this section with respect licensed patent style font time roman time serif margin text align justify nbsp style margin field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section discontinuance settlement tillotts discontinue settle proceeding brought without obtaining concurrence giving timely opportunity continue such proceeding name possible under then applicable under sole control sole expense such discontinuation settlement acceptable rsquo concurrence reasonably withheld unless discontinuation settlement approved university arizona regard those aspect settlement pertaining licensed patent discontinuation settlement will result invalidity unenforceability reduction scope patent claim loss diminution trade secret status licensed information commercial value compromise right receive reasonable compensation infringer rsquo infringement authorized future tillotts third party including infringer anything other than complete release from liability loss alleged counterclaim brought infringer tillotts elect settle those proceeding resolve infringement through grant sublicense infringer with respect tillotts patent right will have same right obligation with respect tillotts patent right tillotts under this section with respect licensed patent style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section sharing award style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection proceeding brought proceeding brought which tillotts join party plaintiff entitled keep account damage that awarded tillotts join proceeding brought party plaintiff then from total damage awarded party severally jointly will first receive amount equal pocket expense cost incurred course that proceeding award made tillotts then recovery will made from award each party proportion award except provided immediately following clause party will share amount remaining equally under clause would receive amount than amount would have received earned royalty that tillotts would have paid infringing product been sold tillotts tillotts rsquo established price licensed product country which those infringing product were sold infringer then will first retain account from awarded damage amount equal those earned that tillotts would have paid then tillotts retain balance account style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection proceeding brought tillotts proceeding brought tillotts which join party must share awarded damage follows tillotts will first keep account amount equal final pocket expense final cost incurred course that proceeding from total damage awarded minus expense cost mentioned tillotts must amount equal earned royalty that tillotts would have paid infringing product been sold tillotts tillotts rsquo established price licensed product country which those infringing product were sold infringer more than half total amount awarded tillotts keep account balance amount awarded damage join proceeding brought tillotts then each party will entitled keep damage expressly awarded allocated after tillotts proportionally recovers from each party rsquo award amount equal pocket expense cost incurred course that proceeding proceeding brought tillotts which join party plaintiff damage awarded then from total damage awarded party severally jointly tillotts will first receive amount equal pocket expense cost incurred course that proceeding award made tillotts then recovery will made from award each party proportion award party will share amount remaining equally style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section indemnification tillotts hereby agrees indemnify defend hold harmless from claim damage other obligation arising resulting from claim legal proceeding instituted tillotts under section foregoing indemnity apply extent incurs claim damage obligation because elected continue proceeding name under section incurs claim damage obligation based solely malfeasance misconduct style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section assignment party agree that this agreement mere license assignment transfer title tillotts ownership right licensed patent licensed information tillotts rsquo ownership right tillotts owned development including tillotts patent right tillotts owned data mediator arbitrator court other tribunal construes this document create assignment party rsquo right interest manner that contradicts previous sentence then other party must cooperate fully promptly executing document reasonably necessary establish party rsquo ownership those right including signing formal assignment document further such instance this agreement will deemed amended whatever respect reasonably necessary ensure that interpreted license based finding such mediator arbitrator court tribunal event proceeding instituted settle dispute concerning this agreement such other party take position contrary this section such other party must require affiliate sublicensees applicable abide this section same extent required such party this section survives expiration termination this agreement reason style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align center article viii style font time roman time serif margin text align center allocation risk style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section responsibility must keep licensed patent licensed information free lien full sole responsibility tillotts sublicensees appropriate care practice licensed product under license control manner which licensed product made make representation warranty whatsoever with respect licensed product sold tillotts affiliate sublicensees marketing distribution sale licensed product licensed territory tillotts rsquo sole discretion sole responsibility style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent section liability limitation thereof style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection liability regard event liable damage loss claim whether direct otherwise arising related wrongful tillotts affiliate sublicensees licensed information sale person licensed product that benefit from availability licensed information sold tillotts affiliate sublicensee tillotts claim third party against tillotts made aforementioned connection except each case extent those damage loss claim arise from rsquo breach obligation entered into hereunder gross negligence willful misconduct obligated under subsection defend indemnify tillotts such claim style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection liability regard tillotts event tillotts liable damage loss claim whether direct otherwise arising related rsquo negligence conduct phase trial claim third party against based this agreement except each case extent those damage loss claim arise from tillotts rsquo breach obligation under this agreement gross negligence willful misconduct tillotts obligated under subsection defend indemnify such claim style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection limitation liability event either party liable other party whether based contract tort loss profit demonstrated prospective business revenue incidental indirect special exemplary punitive consequential damage however caused whether directly indirectly arising this agreement research development generation approval offer sale importation sale licensed product licensed information party sublicensees other person each party hereby release other party from loss damage that type foregoing limitation will apply whether party been advised possiblity those loss damage each party acknowledges agrees that foregoing limitation liability essential element basis bargain between party that absence such limitation material economic term this agreement would substantially different font style text transform uppercase font provision this section survive expiration earlier termination this agreement style font time roman time serif margin text align justify text indent font style text transform uppercase nbsp font style font time roman time serif margin text align justify text indent section warranty disclaimer style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection represents warrant tillotts that effective date right grant license actual knowledge where actual knowledge understood that rsquo without independent investigation practice invention claimed licensed patent licensed information infringement third party rsquo intellectual property right licensed territory existing actually known rsquo effective date received written charge complaint claim demand notice alleging that practice invention claimed licensed patent licensed information infringement intellectual property right third party actual knowledge where actual knowledge understood that rsquo without independent investigation third party infringing licensed patent misappropriated licensed information action suit proceeding hearing investigation complaint claim demand pending rsquo knowledge threatened that challenge legality validity enforceability ownership licensed patent license information licensed patent patent right rsquo ownership control that considers reasonably necessary develop market sell licensed formulation licensed field licensed territory except provided subsection reservation right earlier granted license third party practice under licensed patent licensed information licensed field sale product containing licensed formulation licensed territory style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection limitation disclaimer nothing contained this agreement construed representation warranty that licensed patent patent claim will used prevent importation sale third party product country licensed patent where such product placed commerce under circumstance which applicable treaty preclude licensed patent patent claim prevent such importation sale scope enforceability validity licensed patent patent claim whether patent application within licensed patent will result issued patent except provided subsection that performance practice under patent claim infringement patent others maximum extent prohibited applicable licensed information being provided accepted tillotts ldquo rdquo ldquo with fault rdquo ldquo available rdquo except expressly provided this agreement solely with respect licensed information hereby disclaims maximum extent prohibited applicable express implied warranty term condition however arising including without limitation those related merchantability fitness particular purpose font style text transform uppercase satisfactory quality performance result condition title quiet possession correspondence with description infringement these disclaimer warranty constitute essential part this agreement font style font time roman time serif margin text align justify font style text transform uppercase nbsp font style font time roman time serif margin text align justify text indent section defense third party claim style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection defense third party claim tillotts based activity under this agreement recognition fact that will control tillotts rsquo activity under this agreement tillotts agrees term this agreement year thereafter defend settle claim demand suit action arbitration investigation other proceeding that threatened made instituted behalf third party each ldquo claim rdquo against university arizona their respective representative collectively ldquo defendant rdquo must agreed upon settlement amount loss damage judgment cost whatever kind including without limitation reasonable attorney rsquo expense collectively ldquo loss rdquo incurred awarded against defendant extent those claim loss arise from relate marketing promotion distribution sale offer sale importation licensed product tillotts affiliate sublicensee third party including consumer customer tillotts sublicensees actual alleged breach tillotts provision this agreement including tillotts rsquo representation warranty covenant actual alleged negligence willful misconduct violation applicable tillotts affiliate sublicensee representative tillotts rsquo foregoing obligation apply particular defendant extent claim loss attributable malfeasance willful misconduct defendant although defendant guilty malfeasance willful misconduct will continue benefit from foregoing covenant defense indemnity must promptly notify tillotts claim must reasonably cooperate with tillotts representative investigation defense claim that must promptly notify tillotts receives written notice assertion threatened assertion claim promptly respond reasonable inquiry assistance information that tillotts have long cost responding borne entirely tillotts obligation this section addition lieu tillotts rsquo obligation procure obtain maintain insurance required below style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection defense third party claim based activity outside licensed territory recognition fact that tillotts will control rsquo activity outside licensed territory agrees that obligation defend forth immediately above subsection apply vice versa unlikely case that third party make claim against tillotts activity having taken place outside licensed territory related rsquo performance obligation under this agreement style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent section insurance style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection tillotts tillotts must obtain thereafter throughout term this agreement period year after termination expiration maintain force sole cost expense comprehensive general liability insurance minimum amount occurrence aggregate product liability insurance minimum amount against liability bodily injury death destruction damage property insurance coverage must carried with reputable financially secure insurance company having high rating regarding financial strength payment claim that reasonably acceptable provide endorsed provide that tillotts rsquo insurance primary other insurance carried indemnitees excess contributing with insurance carried tillotts provide endorsed provide that written notice registered mail must given least thirty before termination cancellation reduction coverage from time time upon rsquo request tillotts must provide nbsp with evidence nbsp insurance that required insurance continues effect nbsp insurance coverage limit specified above limit nature amount tillotts rsquo obligation under section above style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection must obtain during period which phase trial being conducted going maintain sole cost expense policy professional general liability insurance amount than occurrence annual aggregate covering obligation under this agreement regarding conduct phase trial including clinical trial liability coverage additionally must obtain thereafter throughout term this agreement period year after termination expiration maintain force sole cost expense comprehensive general liability insurance minimum amount occurrence aggregate product liability insurance minimum amount against liability bodily injury death destruction damage property insurance coverage must carried with reputable financially secure insurance company having high rating regarding financial strength payment claim that reasonably acceptable approved tillotts provide endorsed provide that written notice registered mail must given tillotts least thirty before termination cancellation reduction coverage nbsp from time time upon tillotts rsquo request must provide nbsp tillotts with evidence nbsp insurance that required insurance continues effect nbsp insurance coverage limit specified above limit nature amount rsquo obligation under section above style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align center article style font time roman time serif margin text align center termination style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section termination right style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection unilateral termination tillotts terminate this agreement time giving hundred eighty rsquo written notice tillotts election terminate this agreement subject party rsquo surviving obligation either entirety tillotts rsquo discretion follows japan only certain country licensed territory except japan consequence such termination forth subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection termination breach party materially breach this agreement breaching party terminate this agreement giving breaching party written notice that breach affording breaching party opportunity cure that breach before date thirty after date breaching party written notice party confirm their good faith intention this subsection ldquo easy rdquo this agreement therefore party herewith establish following procedure when come termination this agreement based uncured material breach style font time roman time serif margin text align justify nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify event that breaching party within applicable cure period respond react written notice issued delivered accordance with section notice breaching party termination shall become final definite accordance with time frame mentioned immediately herein below table table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify event that breaching party during breach cure period dispute good faith validity breach claim made breaching party then party shall timely escalate this matter bring attention their respective thereafter party still agree this matter shall decided accordance with section dispute resolution only then this agreement terminated based such breach arbitration panel confirms final written determination that such party committed such material breach failed cure such breach within applicable cure period clarity agreement shall continue effect during pendency such dispute resolution unless during such period agreement expires otherwise properly terminated including pursuant section event that dispute resolution confirms termination then termination shall become effective next business after delivers such final written determination both party table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify breaching party within thirty cure period proposes breaching party credible plan reasonably acceptable breaching party cure such breach which plan upon acceptance breaching party breaching party diligently pursues make substantive effort complete breaching party shall grant breaching party additional ninety otherwise agreed order cure that breach style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent consequence such termination based material breach forth subsection style font time roman time serif margin text align justify text indent nbsp nbsp style font time roman time serif margin text align justify text indent subsection immediate breach termination ldquo financial default rdquo mean voluntary involuntary dissolution bankruptcy insolvency party assignment substantially party rsquo asset benefit creditor specifically include order resolution that part voluntary scheme reconstruction amalgamation such party solvent corporation resulting corporation different legal entity undertakes with other party bound term this agreement without limiting generality foregoing financial default includes circumstance which party unable debt they mature admits writing inability debt they mature make general assignment benefit creditor file voluntary petition bankruptcy filed against involuntary petition bankruptcy that discharged dismissed within ninety after date involuntary filing applies appointment receiver trustee substantially asset permit assignment such receiver trustee discharged within period ninety after such appointment financial default constitutes material breach this agreement upon occurrence financial default party suffering from financial default terminate this agreement upon written notice breaching party style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify consequence such termination based financial default forth subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section extraordinary termination right style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection extraordinary termination event tillotts elect terminate this agreement entirely part licensed territory upon giving specified written notice each following circumstance each ldquo extraordinary termination event rdquo extraordinary termination event considered breach this agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent ninety written notice order that phase trial terminated such order lifted such responding clinical hold imposed under code federal regulation section style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent ninety written notice party agree expert panel defined subsection issue written report setting forth conclusion that style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent development licensed formulation should cease because final analysis after completion phase trial demonstrates that licensed formulation safe provide statistically significant therapeutic prophylactic benefit with respect primary indication disease significant change pertinent regulatory reimbursement regulation after effective date indicate that product will eligible reimbursement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent anticipated peak annual sale value licensed product primary indication disease will than fifty percent previously expected peak sale value based scope nature regulatory approval including pricing reimbursement approval third party rsquo therapeutic entity treat prevent primary indication disease provided that tillotts establishes such previously expected peak sale value with written documentation prepared good faith such previous time tillotts actually relied such documentation purpose managing tillotts rsquo business achieve such expected sale value style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent upon election terminate this agreement accordance with subsection instead exercising continued development option style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent ninety rsquo written notice result rsquo committee orphan medicinal product opinion orphan drug designation licensed formulation primary indication disease withdrawn terminated style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent ninety written notice reason other than force majeure number patient enrolled phase trial date after first enrollment date than total enrollment target after first enrollment date than total enrollment target after first enrollment date than total enrollment target reasonably demonstrate that such deficiency will increase total development cost more than style font time roman time serif margin nbsp style font time roman time serif margin text align justify recommends termination phase trial style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify notifies party writing rsquo final determination that licensed formulation approvable primary indication disease style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify fulfill obligation conduct pediatric trial mentioned style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify termination notice under clause given before date ninety from date that tillotts receives notice about occurrence extraordinary termination event tillotts will deemed have waived right terminate this agreement based this subsection particular event provided however that termination notice under clause given within time frame specified subsection preparation submission prosecution giving notice termination tillotts will deemed have waived right terminate this agreement party receiving information shall responsible forward pertinent information about such event promptly other party style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection termination license japan only tillotts elect terminate this agreement with respect only japan upon giving specified written notice each following circumstance none which will considered breach this agreement subject subsection consequence termination only certain country effect such notice will remove japan from licensed territory this agreement will otherwise continue full force effect such circumstance style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent ninety rsquo written notice pmda order that phase phase phase clinical trial conducted tillotts affiliate japan terminated because occurrence serious adverse event demonstrates that licensed formulation safe style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent ninety rsquo written notice expert panel issue written report that development licensed formulation japan should cease because final analysis after completion phase phase phase clinical trial conclusively demonstrates that licensed formulation safe provide statistically significant therapeutic prophylactic benefit with respect primary indication disease significant change pertinent regulatory reimbursement regulation after effective date indisputably indicate that product will eligible reimbursement japan anticipated annual gross billing licensed product japan will prof than fifty percent rolling forecast based scope nature regulatory approval including pricing reimbursement approval japan third party rsquo therapeutic entity treat prevent primary indication disease style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent ninety rsquo written notice pmda denies rsquo application orphan drug status licensed formulation primary indication disease style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section action upon consequence termination style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection upon tillotts unilateral termination tillotts termination certain extraordinary termination event termination tillotts breach tillotts immediate breach this agreement terminated tillotts pursuant subsection unilateral termination extraordinary termination event pursuant subsection termination breach tillotts immediate breach termination financial default tillotts style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent tillotts must promptly return licensed information tangible electronic form possession control possession control sublicensee affiliate tillotts style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent license will terminate tillotts affiliate sublicensees must cease activity under this agreement except expressly provided under this agreement requested style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent tillotts tillotts rsquo sole expense except that case termination under section shall share such external pocket expense incurred tillotts must promptly assign obtain necessary approval assign tillotts rsquo right title interest approval mark licensed territory tillotts owned data tillotts rsquo right owned data tillotts owned development agreement understanding that tillotts then have place with regulatory authority including reimbursement authority panel distribution sale agreement with distributor independent sale representative licensed territory with respect licensed formulation that tillotts have effect time termination agreement including consulting service agreement right associated with conduct phase trial performance implementation initial development plan tillotts must sole expense prepare execute deliver file appropriate document notice filing with regulatory authority other further assurance that necessary desirable effect record foregoing assignment style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent upon such termination tillotts covenant agrees that affiliate will cease abstain from using incorporating referring those part licensed information that time termination still confidential information accordance with section remain confidential information thereafter reason purpose style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify tillotts must also exercise good faith effort introduce rsquo representative main technical expert that tillotts utilized connection with effort under this agreement person regulatory authority have served point contact inquiry connection with tillotts rsquo effort related licensed formulation approval sublicense terminated tillotts tillotts must require sublicensee comply with this subsection same extent same manner applies tillotts mutatis mutandis font style background color yellow font style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify extent rsquo obligation make payment tillotts terminates this agreement under subection termination breach forth subsection consequence termination tillotts breach style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection upon breach immediate breach this agreement terminated tillotts pursuant subsection termination breach immediate breach termination financial default style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent covenant agrees continue grant tillotts same right based term condition this agreement including limited license before termination this agreement tillotts style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent must sole expense prepare execute deliver file appropriate assurance document notice filing with regulatory authority with other authority that necessary desirable order tillotts continue enjoy benefit right granted based provision this agreement must also exercise good faith effort introduce tillotts rsquo representative main technical expert that utilized connection with effort under this agreement person regulatory authority have served point contact inquiry connection with rsquo effort related licensed formulation approval style font time roman time serif margin text align justify nbsp style font time roman time serif margin extent tillotts rsquo obligation continue royalty forth subsection style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection additional action upon tillotts termination certain extraordinary termination event before date none hundred eighty after effective date termination pursuant subsection will prepare deliver tillotts statement wind down expense ldquo wind down statement rdquo with reasonable supporting documentation style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify tillotts terminates this agreement pursuant subsection based subsection tillotts made continued development election before providing written notice termination then addition action under subsection above that must taken upon such termination tillotts must wind down expense such expense properly vouched shall provide tillotts documentation confirming actual amount wind down expense incurred before date thirty after date tillotts receives undisputed wind down statement tillotts must amount forth wind down statement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify either style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify tillotts terminates this agreement pursuant subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify tillotts terminates this agreement pursuant subsection tillotts made continued development election before providing written notice termination style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify then addition action under subsection above that must taken upon such termination tillotts must reimburse rsquo internal cost including associated further including individual consultant devote least fifty percent their consulting time related development product licensed territory three month period after notice termination incurred conducting phase trial licensed territory amount exceed total million five hundred thousand dollar before date three month after effective date termination event described this paragraph will prepare deliver tillotts statement rsquo internal cost described preceding sentence with reasonable supporting documentation before date thirty after date tillotts receives rsquo statement internal cost tillotts must amount forth that statement style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection consequence termination only certain country reason tillotts rsquo right under this agreement terminate with respect more specific country each such country ldquo terminated country rdquo than entire licensed territory such termination certain country pursuant subsection unilateral termination with respect country licensed territory except japan with respect japan only termination japan only pursuant subsection diligence japan subsection termination license japan only then such terminated country shall automatically excluded from licensed territory style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent tillotts must promptly return licensed information owned data tangible electronic form possession control possession control sublicensee affiliate tillotts relating exclusively such terminated country style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent license will revoked with respect such terminated country tillotts affiliate sublicensees must cease activity such terminated country under this agreement except expressly provided under this agreement requested style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent tillotts cost except that shall share such external pocket expense incurred tillotts must promptly assign right title interest tillotts owned data owned data tillotts owned development mark they relate such terminated country applicable approval they relate such terminated country agreement understanding that tillotts then have place with regulatory authority such terminated country including reimbursement authority panel distribution sale agreement with distributor independent sale representative such terminated country with respect licensed formulation that tillotts have effect time termination agreement including consulting service agreement right associated with conduct clinical trial such terminated country tillotts must prepare execute deliver file cost appropriate document notice filing with regulatory authority other further assurance that necessary desirable effect record foregoing assignment style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent upon such termination tillotts covenant agrees that affiliate will cease abstain from using incorporating referring licensed information that time termination still confidential information accordance with section remain confidential information thereafter reason purpose such terminated country style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent agreement shall continue full force effect with respect remaining country licensed territory excluding terminated country style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection payment upon termination style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent font style font variant small development termination font upon date that after tillotts rsquo termination this agreement pursuant subsection extraordinary termination event must development termination ldquo development termination rdquo equal style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent calculation next page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent amount equal difference arrived performing following calculation style font time roman time serif margin text align justify text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse margin left style vertical align style width text align justify nbsp style width text align justify nbsp style width text align justify font style font size font style vertical align style text align justify font style font size plus font style text align justify nbsp style text align justify font style font size paid first interim development milestone payment font style vertical align style text align justify font style font size plus font style text align justify nbsp style text align justify font style font size paid second interim development milestone payment font style vertical align style text align justify font style font size plus font style text align justify nbsp style text align justify font style font size paid final development milestone payment font style vertical align style text align justify font style font size plus font style text align justify nbsp style text align justify font style font size paid wind down expense pursuant section font style vertical align style text align justify font style font size font style text align justify nbsp style text align justify font style font size actual development cost defined below font style vertical align style text align justify font style font size equal font style text align justify nbsp style text align justify font style font size development termination greater than zero font table style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent ldquo actual development cost rdquo shall considered actual cost incurred after december plus those cancellable cost which obligation accrued develop licensed formulation through effective date termination provided however that period between notice termination effective date such termination actual development cost such period shall exceed wind down expense purpose this subsection that date would effective date termination pursuant subsection provided however that shall development termination long none milestone payment mentioned this subsection have been paid style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify determining amount paid final development milestone payment amount final development milestone payment applied purchase restricted stock included style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify example without limitation actual development cost through effective date termination were wind down expense were first interim second interim final development milestone payment been made tillotts development termination would calculated follows style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse margin left style vertical align style width text align justify nbsp style width text align justify nbsp style width text align justify font style font size font style vertical align style text align justify font style font size plus font style text align justify nbsp style text align justify font style font size paid first interim development milestone payment font style vertical align style text align justify font style font size plus font style text align justify nbsp style text align justify font style font size paid second interim development milestone payment font style vertical align style text align justify font style font size plus font style text align justify nbsp style text align justify font style font size paid final development milestone payment font style vertical align style text align justify font style font size plus font style text align justify nbsp style text align justify font style font size paid wind down expense pursuant section font style vertical align style text align justify font style font size font style text align justify nbsp style text align justify font style font size actual development cost font style vertical align style text align justify font style font size equal font style text align justify nbsp style text align justify font style font size development termination font table style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent font style font family time roman time serif font variant small consequence font font style font variant small termination tillotts breach font terminates this agreement under subsection termination breach above based tillotts rsquo uncured material breach style font time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify rsquo termination date sending remedy notification before acceptance application submitted tillotts there shall further payment tillotts table style font time roman time serif margin text align justify nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify rsquo termination date sending remedy notification after acceptance application submitted tillotts shall tillotts royalty sale value licensed territory product that formerly licensed formulation total aggregate amount more lump payment equal such total aggregate amount that will determined status licensed formulation licensed territory date such notice delivered forth following table ldquo right assumption rdquo table style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse margin left style vertical align style width text align justify border bottom black solid font style font size status licensed formulation font style width nbsp style width text align justify border bottom black solid font style font size total aggregate payment font style vertical align style text align justify nbsp nbsp style text align justify nbsp style vertical align style text align justify font style font size application accepted approved country font nbsp style text align justify font style font size font style vertical align style text align justify nbsp nbsp style text align justify nbsp style vertical align style text align justify font style font size pricing reimbursement approved more country font nbsp style text align justify font style font size font style vertical align style text align justify nbsp nbsp style text align justify nbsp style vertical align style text align justify font style font size approved country sale value immediately prior four full calendar quarter exceeded font nbsp style text align justify font style font size font table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify clarity discretion applicable total aggregate amount through royalty more lump payment combination foregoing provided however that must royalty that described subsection immediately above table unless until date that paid applicable total aggregate amount full whether through royalty lump payment style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font variant small termination breach immediate breach font tillotts terminates this agreement under subsection termination breach above based rsquo uncured material breach under subsection immediate breach termination style font time roman time serif margin text align justify text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify tillotts rsquo termination date date sending remedy notification before submission application tillotts then tillotts rsquo payment shall equal amount forth section earned royalty section sale milestone payment payable term forth therein provided however that tillotts shall entitled credit sale milestone payment under section royalty payment under section equal amount expense tillotts incurred developing licensed formulation between date such termination became effective date first approval licensed territory extent reasonably documented customary table style margin margin bottom nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width style text align justify tillotts rsquo termination date sending remedy notification after submission application tillotts tillotts shall royalty sale milestone forth section earned royalty section sale milestone payment table style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent font style font variant small enhanced right assumption upon approval acceptance font approves rsquo drug application directed licensed formulation primary indication disease directed licensed formulation primary indication filed with finally formally declared approvable after full review that after reasonable administrative legal remedy have been exhausted excluding commencement lawsuit against regulatory authority tillotts elect terminate this agreement pursuant subsection will tillotts royalty equal total annual sale value product comprising licensed formulation sold licensee distributor other related party united state america licensed field follows royalty shall from later date first commercial sale licensed formulation united state america date such termination this agreement tillotts became effective until maximum amount payment forth below paid full quarterly payment will made later than sixty calendar after respective calendar quarter foregoing purpose definition ldquo sale value rdquo ldquo total annual sale value rdquo will applied sale licensee united state america mutatis mutandis total amount payable under this paragraph this subsection will exceed twenty million dollar plus amount added thereto operation subsection amount those listed payment that have been applied purchase restricted stock contemplated herein result being referred ldquo enhanced right assumption rdquo with each payment will provide report showing applicable total annual sale value computation corresponding payment under this paragraph this subsection with respect thereto remaining balance enhanced right assumption remaining after applying that payment style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section surviving obligation tillotts obligation amount payable under this agreement report earned royalty licensed product sold before expiration earlier termination this agreement survive that expiration earlier termination rsquo obligation amount payable tillotts under subsection tillotts rsquo obligation under subsection survive expiration earlier termination this agreement addition provision this agreement that expressly provides obligation continue beyond expiration earlier termination this agreement provision forth exhibit shall survive expiration earlier termination this agreement together with other provision necessary effect intent this agreement expiration earlier termination this agreement constitute termination waiver right either party against other party accruing before time expiration termination field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section effect termination this agreement sublicenses either party provides notice that this agreement will terminated sublicense force effect date such notice then tillotts shall within thirty after such notice provide list such sublicenses then effect that will terminate automatically with termination this agreement together with description breach applicable sublicensee under such sublicenses whether when such breach were cured with respect each such sublicense neither party such sublicense material breach such sublicense time this agreement terminates tillotts right assign such sublicense then will consider good faith whether discretion accept such assignment provided that such sublicensee permit conduct reasonable diligence such sublicensee rsquo business practice agrees amend sublicense conform rsquo reasonable request including related compliance with applicable anti corruption provision style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section reverter upon termination this agreement except otherwise expressly provided this agreement license right granted from tillotts under this agreement will immediately automatically completely revert sole benefit style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align center article style font time roman time serif margin text align center purchase restricted stock style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent tillotts rsquo election purchase share restricted stock pursuant subsection bridge financing total development cost consented deficiency payment will according following term style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent tillotts will enter into stock purchase agreement containing customary investor representation warranty required federal state security united state corresponding customary restriction transfer style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent share restricted stock will subject customary underwriter lock covenant other similar restriction imposed other holder share including right first refusal drag along right like style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent certificate representing share restricted stock will bear legend required applicable style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent purchase price share will equal greatest price share preferred stock sold rsquo most recent financing share value restricted stock determined independent valuation expert rsquo choosing reasonably acceptable tillotts trading average share common stock twenty trading period immediately preceding date which those share purchased those share then traded public exchange otherwise mutually agreed party style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent tillotts will receive respect share restricted stock emptive right registration right style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify closing purchase share restricted stock will occur rsquo office before date that three month after date first legally able sell such restricted stock such other date party mutually agree promptly after closing that purchase will issue tillotts certificate representing share restricted stock style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align center article style font time roman time serif margin text align center miscellaneous style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section agreement entirety this agreement exhibit supply agreement when executed delivered party represent constitute entire agreement between party subject matter those document prior contemporaneous oral written negotiation representation warranty agreement statement promise understanding with respect that subject matter merged into extinguished superseded completely expressed those document party bound charged with written oral agreement representation warranty statement promise understanding specifically forth such document style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section address notice notice request consent demand other communication provided this agreement must writing will deemed have been made given date delivered personally delivered sent facsimile confirmed delivery other mean permitted under this section date time transmission indicated received facsimile sent during normal business hour notified party next business nbsp date business after being sent registered certified mail return receipt requested postage prepaid nbsp date after deposit with internationally recognized overnight courier specifying delivery with written verification receipt notice must addressed party entitled notice address indicated below such other address such party designate advance written notice under this section other party this agreement style font time roman time serif margin text align justify nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text decoration underline text align justify font style font size font style width text decoration underline text align justify font style font size tillotts font style vertical align style text align justify nbsp style text align justify nbsp style vertical align style text align justify font style font size cancer prevention pharmaceutical font style text align justify font style font size tillotts pharma font style vertical align style text align justify font style font size river road suite font style text align justify font style font size baslerstrasse font style vertical align style text align justify font style font size tucson nbsp nbsp font style text align justify font style font size rheinfelden font style vertical align style text align justify font style font size font style text align justify font style font size switzerland font style vertical align style text align justify font style font size attention font style text align justify font style font size attention font style vertical align style text align justify font style font size facsimile font style text align justify font style font size facsimile font table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify notice will considered ldquo written rdquo ldquo writing rdquo conventional paper facsimile notice change address will effective only when done accordance with this section style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp nbsp style font time roman time serif margin text align justify text indent section amendment this agreement waiver supplement modification amendment this agreement will binding unless executed writing both party party express implied waiver consent provision this agreement other party breach obligation hereunder deemed construed consent waiver other provision other breach same other obligation other party party failure matter long complain failure other party declare other party default irrespective long default continues insist upon strict performance obligation condition this agreement exercise right remedy consequent upon breach thereof constitute waiver that party right breach other obligation condition party consent instance limit waive necessity obtain that party consent future instance single partial exercise right power privilege party hereunder precludes other further exercise thereof exercise other right power privilege such party event consent waiver amendment effective purpose hereunder unless that consent waiver amendment writing allowed purpose giving notice under this agreement that writing signed otherwise confirmed coming from party granting that consent waiver entering into amendment style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section applicable this agreement effect subject must construed enforced accordance with england without regard principle regarding conflict issue that depends upon validity scope enforceability licensed patent must determined accordance with applicable patent country that licensed patent style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section assignment neither party assign this agreement license right obligation duty under this agreement without other party rsquo prior written consent which consent unreasonably withheld delayed assign this agreement tillotts then default under this agreement assign this agreement without assigning party prior written consent business entity with which merges consolidates business entity purchasing substantially assigning party rsquo asset business affiliate case assignment this agreement pursuant immediately preceding sentence assigning party must nonetheless give assigning party prior written notice that assignment require cause successor business entity sign deliver written agreement form substance satisfactory assigning party expressly assume agree perform this agreement abide term assume obligation assigning party same manner same extent that assigning party would required perform succession taken place when properly assigned this agreement will binding upon inure benefit enforceable party their respective successor assigns style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent font style font size section compliance with severability nothing this agreement intended construed require authorize commission contrary applicable font font style font size provision this agreement which applied narrowest sense meaning particular provision within single section subsection paragraph sentence clause conflict with statute ordinance policy treaty such that held adjudged invalid illegal void otherwise unenforceable then affected provision must curtailed limited only extent necessary bring within applicable legal requirement validity legality enforceability remaining provision this agreement will affected impaired thereby will remain enforceable fullest extent permitted that event fullest extent possible remaining provision this agreement will modified construed extent necessary resolve conflict give effect intent manifested provision held invalid illegal void unenforceable font style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section computation time computing period time purpose this agreement date notice event default from which designated period time begin will included last period computed will included unless saturday sunday national holiday switzerland federal holiday united state which event period until next which saturday sunday holiday reference month quarter year reference calendar calendar month calendar quarter calendar year unless otherwise indicated reference ldquo business rdquo ldquo working rdquo reference that saturday sunday holiday style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section confidentiality provision this section associated provision this agreement supersede replace entirety that certain confidential disclosure agreement between tillotts made effective march style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection generally provision this section apply ldquo confidential information rdquo defined below avoidance doubt provision this section apply licensed information confidential treatment which governed section above ldquo confidential information rdquo mean term this agreement part rsquo royalty report hereunder other party communication written otherwise information contained therein between party between party regulatory authority concerning phase trial adverse drug experience preparation filing review information communication written otherwise concerning prosecution prosecution strategy defense assertion licensed patent including content communication under article information obtained party from inspection other party rsquo book record pursuant this agreement minute record recommendation during term this agreement time thereafter receiving party must maintain confidential information confidence disclose divulge otherwise communicate portion third party except director officer employee agent investor potential investor acquirer potential acquirer licensee potential licensee advisor accounting legal investment banking prospective assigns bound like term confidentiality purpose except pursuant order carry term objective this agreement assert enforce right other party rsquo obligation under this agreement receiving party further agrees exercise every reasonable precaution prevent restrain unauthorized disclosure such confidential information director officer employee agent provision this section apply confidential information that time receipt party independently known that party from source other than other party this agreement anyone acting behalf them time party discloses third party generally known public through fault that party time party discloses third party been made available free obligation confidentiality receiving party third party having lawful right without breaching obligation nonuse confidentiality shown competent documentary evidence have been independently developed receiving party provision subsection through incorporated herein this reference applied confidential information disclosed party another hereunder mutatis mutandis confidential information will deemed owned party disclosed style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection publicity publication neither party name logo other party university arizona adaptation name advertising promotional sale literature without prior written consent obtained from pertinent person each party must require affiliate sublicensees comply with foregoing promptly after execution delivery this agreement party must prepare agree upon content press release announcing agreement term general nature party rsquo relationship obligation under this agreement regard matter arising under this agreement from time time that required suitable public dissemination that appropriate publication scientific trade journal like will determine content timing such publication foregoing prohibit disclosure that required court order rule stock exchange other entity where party rsquo security traded listed connection with filing registration party rsquo security with governmental authority stock exchange case pending disclosure permitted under immediately preceding sentence party making that disclosure must inform other party writing intended disclosure before making that disclosure give other party opportunity comment suggest modification limitation intended disclosure before made party intending make that disclosure must consider good faith comment suggestion other party although final decision content nature disclosure require comply with applicable regulation order will rest with party intending make that disclosure extent disclosure required order court regulatory investigatory authority legal proceeding administrative action party will cooperate obtaining protective order preserve much reasonably possible confidential treatment disclosed information otherwise limit prevent such disclosure which event must limited that required comply with court administrative order notwithstanding disclosure connection with legal proceeding administrative action party must continue treat disclosed confidential information accordance with this section other instance respect style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section counterpart this agreement executed more identical counterpart each which will deemed original which taken together will constitute same instrument delivery executed counterpart signature facsimile transmission electronic mail portable document format form another electronic mean intended preserve original graphic pictorial appearance document will have same force effect physical delivery original paper document bearing original signature each party facsimile signature evidence execution delivery agreement party same extent that original signature could used style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section dispute resolution party must make every reasonable effort resolve dispute relating this agreement construction breach face face negotiation between senior executive those negotiation fail resolve dispute either party submit dispute final binding arbitration conducted london england metropolitan area accordance with rule international chamber commerce ldquo rdquo party required choose arbitration administrator member arbitration panel required arbitrator registered with judgment upon award rendered entered highest court forum having jurisdiction over party style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section export each party will comply fully with relevant export regulation country into which licensed information imported which licensed product made used sold offered sale imported ensure that licensed information licensed product exported directly indirectly violation those export intended used purpose prohibited those export style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section force majeure failure omission party performance obligation this agreement except payment hereunder will deemed breach this agreement create liability failure omission arises from cause beyond control party question step that could taken mitigate eliminate cause failure omission were reasonably foreseeable were reasonably available commercially practicable failure omission caused exacerbated negligence performing party nbsp style font time roman time serif margin text align justify cause falling within clause above include omission government agency thereof compliance with governmental authority officer department agency instrumentality thereof fire storm flood earthquake accident public enemy declared undeclared rebellion insurrection riot sabotage invasion quarantine restriction strike lockout dispute difference with workman transportation embargo delay transportation that event performing party must give other party prompt written notice upon discovery reasonable effort continue perform cure style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section independent contractor performance under this agreement each party independent contractor neither party their respective representative representative other party nothing this agreement construed authorization party agent other this agreement constitute create interpreted joint venture partnership formal business organization kind style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section third party beneficiary none provision this agreement benefit enforceable third party agreement herein contained made sole benefit party hereto other person entity intended shall have right benefit hereunder whether third party beneficiary otherwise style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section patent marking tillotts will exercise commercially reasonable effort mark licensed product packaging shipping container licensed product indicating extent true that licensed product covered claim licensed patent including legible notice manner suitable each licensed product indicating that licensed product covered claim licensed patent paperwork accompanying licensed product such package insert indicating that licensed product covered claim licensed patent style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section representation style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection power authority binding agreement compliance with each party represents warrant other that duly organized validly existing good standing under jurisdiction organization formation full power authority enter into deliver perform obligation under carry provision this agreement person executing this agreement behalf such entity been duly authorized such person duly signed delivered this agreement this agreement constitutes valid binding agreement representing warranting party action required taken authorize execute deliver perform under this agreement been taken further approval governing person necessary consummate this agreement execution delivery performance this agreement representing warranting party conflict with other agreement arrangement which such entity party which bound will comply with applicable rule regulation directive exercise good faith performing under this agreement without limiting foregoing clause tillotts affiliate shall comply with applicable anti corruption regulation including bribery shall cooperate with connection with audit investigation related thereto rsquo request tillotts shall discus good faith unreasonably withhold consent supplementing this agreement with additional anti corruption related provision before submission tillotts affiliate sublicenses application marketing other regulatory approval licensed product style font time roman time serif margin text align justify nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection debarment each party represents warrant other that neither representative ever been currently subject proceeding that could lead representative becoming applicable debarred entity debarred individual excluded person convicted person each which term defined below making foregoing representation warranty each party certifies other path that date this agreement warranting party screened itself representative against exclusion list defined below that informed other party path whether representative been placed exclusion list each party further covenant represents warrant that during term this agreement representative become subject proceeding that could lead person becoming applicable debarred entity debarred individual excluded entity excluded individual convicted entity convicted individual that party must immediately notify other party must immediately remove that person from performance under this agreement after execution this agreement each party must notify other party writing immediately representative appears exclusion list ldquo debarred entity rdquo corporation partnership association that been debarred pursuant sect corresponding foreign regulation applicable from submitting assisting submission abbreviated drug application subsidiary affiliate debarred entity ldquo debarred individual rdquo individual been debarred pursuant sect corresponding foreign regulation applicable from providing service capacity person that approved pending drug biological product application ldquo convicted person rdquo individual entity applicable been convicted criminal offense that fall within ambit sect sect corresponding foreign regulation applicable been excluded debarred suspended otherwise declared ineligible ldquo excluded person rdquo person that been excluded debarred suspended otherwise ineligible participate federal health care program including medicare medicaid office inspector general department health human service convicted felony identified among exclusion authority listed department health human service office inspector general website including http fraud exclusion authority been excluded debarred suspended otherwise ineligible participate federal procurement procurement program including those person appearing general service administration list party excluded from federal program http epls those identified list excluded individual entity leie database http fraud exclusion exclusions_list ldquo exclusion list rdquo listing identified clause immediately preceding sentence style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section further assurance each party must take whatever additional action execute whatever additional document other party reasonable judgment deem necessary advisable carry effect more obligation restriction imposed party under this agreement style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent section change control event that party this agreement change control control changed term condition this agreement shall survive such change shall remain fully valid style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align center article style font time roman time serif margin text align center rule interpretation certain definition style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent section certain rule interpretation style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection interpretation term ldquo include rdquo term ldquo include rdquo conjugated verb cognate noun form mean ldquo include without limitation rdquo ldquo include limit rdquo regardless whether word ldquo without limitation rdquo ldquo limited rdquo their equivalent actually follow style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection conjugated verb form cognate noun form term word phrase defined other grammatical form such conjugated verb form cognate noun form have corresponding meaning word phrase capitalized then word phrase must interpreted accordance with commonly used meaning although word phrase that have well known technical trade meaning must interpreted accordance with that meaning style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection gender number whenever used this agreement singular includes plural plural include singular masculine feminine gender neutral pronoun includes other trust partnership limited liability company firm corporation context meaning this agreement require style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection heading heading various article section subsection this agreement used solely convenience party form part this agreement intended affect interpretation meaning this agreement define limit extend describe scope intent style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection recital article integral this agreement reference this agreement ldquo agreement rdquo ldquo this agreement rdquo encompass article style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection presumption each party reviewed this agreement benefit representation counsel light foregoing rule construction effect that ambiguity resolved against drafting party apply interpretation this agreement style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent section definition certain term which appear initially capitalized term this agreement listed defined below exhibit which included convenience provided however that there conflict between definition this section those exhibit then definition this section shall control style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection ldquo adverse drug experience rdquo mean adverse drug experience degree then current edition guideline sect sect other corresponding relevant regulation country licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo affiliate rdquo mean entity which directly indirectly control controlled under common control with party this agreement where purpose this definition ldquo control rdquo constitutes right cast right direct casting more than vote meeting owner that entity meeting entity director governing body right designate majority entity director member entity governing body power direct cause direction management policy entity whether through ownership voting security contract otherwise style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo arizona license rdquo mean that certain license agreement between cancer prevention pharmaceutical llcpp arizona board regent behalf university arizona made effective amended style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo arizona technical information rdquo mean technical information defined arizona license that subject arizona license style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo challenge proceeding rdquo mean lawsuit arbitration other proceeding before tribunal including examination issue third party observation other proceeding procedure before governmental patent authority contesting validity patent claim seeking judgment declaratory otherwise determination that patent claim invalid unenforceable otherwise patentable contesting substantial nature regulatory value licensed information style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo commercially reasonable diligence rdquo defined subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo compound rdquo mean difluoromethylornithine also known eflornithine dfmo designated style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo develop rdquo conjugated verb form cognate noun form thereof mean conduct scientific technical regulatory activity including limited pharmaceutical formulation development clinical toxicological process development manufacturing clinical study include commercial manufacturing style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo diagnostic licensed product rdquo mean diagnostic diagnostic required part treatment regimen licensed product manufacture sale offer sale importation diagnostic diagnostic alone connection with administration licensed product would covered patent claim development manufacturing regulatory approval labeling marketing sale commercialization that diagnostic diagnostic alone connection with administration licensed product been supported benefitted from access licensed information which embodies incorporates made with benefit licensed information style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo distinct formulation rdquo mean formulation compound that interchangeable formulation style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo rdquo mean european medicine agency successor entity thereof style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo rdquo mean germany united kingdom france italy spain collectively style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection ldquo country rdquo mean germany united kingdom france italy spain style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo expert panel rdquo defined subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo rdquo mean united state food drug agency successor thereof style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo first enrollment date rdquo mean date which least twelve site phase trial anticipated effective date first patient enrolls with intent treat phase trial being understood that mere screening patient constitute enrollment style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo first commercial sale rdquo mean with respect each country licensed territory first sale tillotts sublicensee that country licensed product based approval that country approved commercial sale administration human subject monetary compensation negotiated determined rsquo length basis style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo gastrointestinal disease rdquo mean disease condition that affect organ gastrointestinal tract including liver biliary system pancreas gall bladder style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection ldquo indicated disease rdquo mean primary indication disease secondary indication disease additional gastrointestinal disease that party include within scope this definition manner provided subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo initial development plan rdquo defined subsection style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo intellectual property right rdquo mean right granted under applicable person with respect nbsp work authorship including without limitation exclusive exploitation right copyright moral right mask work trade secret right patent patent application disclosure including without limitation reissue division reexamination extension provisionals continuation continuation part thereof design other industrial property right trademark trade dress similar right based designation origin nbsp registration application renewal extension continuation division reissue like based deriving from foregoing style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent font style font size subsection ldquo interchangeable formulation rdquo mean case where licensed formulation that been granted approval indicated disease fixed dose combination proposed formulation compound sulindac active ingredient single fixed dose combination wherein dose compound combination milligram sulindac dose combination milligram whole multiple both same proportion pharmaceutical formulation tablet capsule granular powder form compound font font style font size that with respect tablet capsule form dose than compound such form being frac whole number multiple dose compound being used respective licensed product clarity oral liquid form compound interchangeable formulation font style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo japan development cost rdquo mean total cost developing obtaining approval commercializing licensed formulation japan style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo licensed field rdquo mean therapeutic treatment prophylaxis gastrointestinal disease style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo licensed formulation rdquo mean formulation containing compound fixed dose combination with sulindac free dose combination with sulindac free dose combination include product configuration which sulindac integrally packaged with compound formulation which compound intended labeled administration without concurrent administration sulindac style font time roman time serif margin text align justify nbsp style margin field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent subsection ldquo licensed information rdquo mean following information owned controlled effective date owned data excluding data generated additional study funded solely that contribute reasonably necessary development approval sale product based containing licensed formulation including know owned controlled relating formulation administration licensed formulation included licensed patent technical clinical clinical data owned controlled relating safety efficacy dosing regimen chemical physical property biological effect contraindication other aspect treating gastrointestinal disease with licensed formulation that useful exercise right granted under this agreement obtain approval country licensed territory including owned data owned development regulatory filing approval including regulatory dossier data contained incorporated referenced therein extent issued owned controlled registered name country licensed territory relating administration licensed formulation treat prevent indicated disease arizona technical information style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo licensed patent rdquo mean patent patent application identified exhibit attached this agreement patent patent application that added this agreement exhibit operation subsection divisional continuation whole part application based foregoing issued unexpired patent resulting from application described above issued unexpired amended foreign patent reissue reexamination renewal extension patent term restoration that based patent described above style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo licensed product rdquo mean pharmaceutical preparation containing licensed formulation intended labeled administration licensed field including product manufacture sale offer sale importation which would covered patent claim development manufacturing approval labeling marketing sale commercialization which been supported benefitted from access licensed information style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo licensed territory rdquo mean following country andorra austria belgium bulgaria croatia cyprus czech republic denmark estonia finland france germany greece hungary iceland ireland italy japan latvia liechtenstein lithuania luxembourg malta monaco netherlands norway poland portugal romania marino slovakia slovenia spain sweden switzerland united kingdom vatican city country that added operation subsection after effective date country that part licensed territory admitted european union that country will deemed added licensed territory automatically effective upon that country rsquo admission european union additional action notice party will required effect that addition after effective date country that part licensed territory leaf european union that country will nonetheless continue part licensed territory style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo rdquo mean federal centralized community wide drug application marketing authorization application drug submission health registration common technical document other license permit filed with issued approved regulatory authority approval which required before commercial sale licensed formulation pharmaceutical medicinal product administration human excluding pricing reimbursement approval each case together with required subsequent submission supplement amendment thereto style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection ldquo approval rdquo mean approved accepted issued regulatory authority consequent grant right sell licensed formulation licensed field pharmaceutical medicinal product corresponding related approval license registration authorization granted issued regulatory authority style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo sale value rdquo licensed product mean actual billing sale that licensed product determined follows licensed product sold tillotts sublicensee third party that related party actual billing will tillotts rsquo that sublicensee rsquo actual gross invoice amount case licensed product sold tillotts sublicensee related party subsequent sale actual billing will that related party rsquo actual gross invoice amount that subsequent sale actual billing will determined based licensed product sold dosage form suitable final usage administering physician other consumer sold that form actual billing will determined converting quantity licensed product actually sold into quantity that would have been sold final dosage form multiplying that adjusted quantity customary unit price licensed product sold each pertinent country final dosage form when factually applicable taken following deduction shall deducted from actual billing determined above sale duty other governmental charge imposed upon particular sale extent included separate charge amount actual billing amount allowed credited rejection return including recall extent such licensed product replaced supplier normal customary discount including cash discount discount payors health insurance similar organization government organization rebate paid credited accrued actually taken including chargebacks mandated retroactive price reduction adjustment made under tillotts rsquo program designed enhance availability licensed product income patient each case extent actually allowed granted from billed amount charge freight postage shipping freight allowance outbound transportation cost including respective insurance paid extent included separate charge amount actual billing actual uncollectible account receivables extent reflected tillotts rsquo book billing deduction will determined accordance with accrual method accounting accordance with principle international financial reporting standard ifrs applied consistent basis other allowance deduction made including allowance deduction commission sale whatever name known purpose converting dollar sale value invoice price currency other than dollar tillotts must first determine sale value tillotts functional currency converting pertinent foreign currency thereafter convert such value into dollar then determine earned royalty payable licensed product united state currency average daily exchange rate that foreign that functional currency over calendar quarter which sale made determined reference currency converter table fxdaily published oanda subsection applicable then term ldquo tillotts rdquo this definition shall replaced with ldquo rdquo purpose determining rsquo payment obligation under subsection style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo optional information rdquo mean regulatory filing approval data contained incorporated referenced therein extent owned controlled registered name with respect optional territory country that been added licensed territory operation subsection style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection ldquo optional territory country rdquo mean following country collectively afghanistan albania armenia azerbaijan belarus bosnia herzegovenia egypt georgia iraq israel jordan kazakhstan kuwait kyrgyzstan lebanon macedonia moldova montenegro oman philippine qatar russia saudi arabia serbia tajikistan turkey ukraine united arab emirate uzbekistan style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo patent claim rdquo mean valid claim unexpired licensed patent patent claim presumed valid enforceable unless until been held invalid unenforceable final judgment court competent jurisdiction from which appeal taken purpose this agreement especially purpose royalty determination payment under section claim being presented pending patent application deemed equivalent valid claim issued unexpired patent consideration agreement grant license under patent issuing thereon tillotts must earned royalty thereto though were issued valid patent claim style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo phase trial rdquo defined section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo pmda rdquo mean japanese pharmaceutical medical device agency that charged with regulation approval pharmaceutical medicine successor agency thereof style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo primary indication disease rdquo mean familial adenomatous polyposis human style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo regulatory authority rdquo mean regulatory agency ministry department other governmental body having authority country region licensed territory control development manufacture pricing marketing sale product including including committee orphan medicinal product pmda style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo regulatory dossier rdquo mean filed with regulatory authority corresponding related post filing with approval authorization issued regulatory authority pertaining licensed formulation corresponding technical regulatory registration necessary conduct clinical trial licensed formulation manufacture labeling distribution marketing sale import reimbursement export licensed formulation jurisdiction regulatory authority approval regulatory authority style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo reimbursed price rdquo mean reimbursed price purchase licensed product final consumer licensed product established approved applicable regulatory authority style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent font style font size subsection ldquo related party rdquo mean with respect party font font style font size party affiliate person enjoying special course dealing with that party affiliate example limitation quot special course dealing quot includes marketing arrangement between party third party wherein third party sell licensed product arrangement under which third party will sell licensed product under private labeling arrangement with that party supply contract which party agrees with third party supply manufacture licensed product sale third party under such third party name mark barter arrangement which party exchange licensed product other product kind distributor licensed product under party rsquo affiliate rsquo name mark related party party affiliate share either directly indirectly proceeds from distributor sale licensed product font style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo representative rdquo mean director officer employee agent consultant attorney accountant subcontractor party affiliate party style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo restricted stock rdquo mean unregistered common stock value share style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo royalty term rdquo mean country country licensed product licensed product basis period commencing upon first commercial sale pertinent licensed product given country ending later date expiration last expire licensed patent pertinent country licensed territory after accounting renewal extension patent term restoration that based licensed patent pertinent licensed product latest date expiration data market exclusivity conferred pertinent licensed product pertinent country licensed territory expires whether based orphan designation other regulatory exclusivity date that twelve year from date first commercial sale first licensed product that country style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo secondary indication disease rdquo mean colon adenoma human style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo sell rdquo cognate noun form conjugated verb form thereof mean sell otherwise part with dispose value whether cash proceeds barter service value licensed product deemed sold upon transfer title licensed product from seller buyer style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo sublicense rdquo mean sublicense granted under section style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo sublicensee rdquo mean third party which right granted under sublicense style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo total annual sale value rdquo mean aggregate sale value quarterly sale value properly calculated accordance with section summed across licensed product sold used imported into licensed territory given calendar year more tillotts affiliate sublicensees style font time roman time serif margin text align justify text indent nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent subsection ldquo total development cost rdquo mean total cost incurred after august developing licensed formulation according initial development plan latest approved version licensed territory excluding japan development cost cost conducting additional study style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo total enrollment target rdquo mean total number patient targeted enrollment phase trial specified protocol style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo rdquo cognate noun form conjugated verb form thereof mean commercial purpose style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo valuation expert panel rdquo defined subsection style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align justify text indent subsection ldquo wind down expense rdquo mean development licensed formulation primary indication disease licensed territory pocket expense returnable already accounted material that received before date that termination notice under this agreement given pocket expense accountable during three month period immediately following date that notice termination given which subject cancellable commitment under contract purchase order service agreement made issued before date that termination notice under this agreement given rsquo internal cost including associated related development licensed formulation licensed territory three month period immediately following date that notice termination under this agreement given cost related cancellation termination return respective commitment contract material long such cost lower comparison cost related fulfillment such contract those cost shall accountable wind down expense only such commitment contract reflect market standard condition style font time roman time serif margin text align justify text indent nbsp style font time roman time serif margin text align center remainder page left blank intentionally style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center signature immediately follow style font time roman time serif margin text align center nbsp field page sequence value style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width text align center field sequence type arabic name pageno field sequence style width text align right nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align justify text indent witness whereof party hereto have each caused duly authorized officer sign this agreement effective effective date style font time roman time serif margin text align justify nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align colspan font style font size cancer prevention pharmaceutical font nbsp colspan font style font size tillotts pharma font style vertical align colspan nbsp nbsp colspan nbsp style vertical align style width font style font size font style width border bottom black solid padding left font style font size jeffrey jacob font style width nbsp style width font style font size font style width border bottom black solid padding left font style font size dirk reckert font style vertical align nbsp font style font size jeffrey jacob font nbsp nbsp font style font size dirk reckert chief business development officer font style vertical align nbsp nbsp nbsp nbsp nbsp style vertical align style text align justify font style font size date font style border bottom black solid text align justify padding left font style font size font nbsp style text align justify font style font size date font style border bottom black solid text align justify font style font size font style vertical align colspan style text align justify nbsp nbsp colspan style text align justify nbsp style vertical align colspan style text align justify font style font size nbsp font nbsp style text align justify font style font size font style border bottom black solid text align justify padding left font style font size yves kesch font style vertical align colspan style text align justify nbsp nbsp style text align justify nbsp style text align justify font style font size yves kesch general counsel font style vertical align colspan style text align justify nbsp nbsp colspan style text align justify nbsp style vertical align colspan style text align justify nbsp nbsp style text align justify font style font size date font style border bottom black solid text align left padding left vertical align font style font size font table style font time roman time serif margin nbsp style font time roman time serif margin text align center margin bottom signature page ndash license agreement between style font time roman time serif margin text align center margin bottom tillotts cancer prevention pharmaceutical style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align center exhibit mdash patent right style font time roman time serif margin text align center nbsp style font time roman time serif margin text align justify carcinoma diagnosis treatment based genotype style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify patent application style font time roman time serif margin text align justify nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align justify font style font size country font nowrap style width nbsp nowrap style width border bottom black solid text align justify font style font size patent appln font nowrap style width text align justify nbsp nowrap style width border bottom black solid text align justify font style font size filing date font style vertical align style text align justify font style font size font nbsp style text align justify font style font size font style text align justify nbsp style text align justify font style font size font style vertical align style text align justify font style font size japan font nbsp style text align justify font style font size font style text align justify nbsp style text align justify font style font size font table style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify text indent nationalized filing based wipo filed style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify cancer prevention treatment method based dietary polyamine content style font time roman time serif margin text align justify nbsp style font time roman time serif margin text align justify patent application style font time roman time serif margin text align justify nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align justify font style font size country font nowrap style width text align justify nbsp nowrap style width border bottom black solid text align justify font style font size patent appln font nowrap style width text align justify nbsp nowrap style width border bottom black solid text align justify font style font size filing date font style vertical align font style font size font nbsp font style font size font nbsp font style font size font style vertical align font style font size japan font nbsp font style font size font nbsp font style font size font table style font time roman time serif margin nbsp style font time roman time serif margin text indent nationalized filing based wipo filed style font time roman time serif margin text indent based filed style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align center exhibit ndash style font time roman time serif margin attached style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin margin bottom text align center exhibit ndash style font time roman time serif margin text align center nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align style width text align justify font style font size approved tillotts font style width text align justify font style font size signature font style width text align justify font style font size date font style vertical align style text align justify nbsp style text align justify nbsp style text align justify nbsp style vertical align style text align justify font style font size approved font style text align justify font style font size signature font style text align justify font style font size date font table style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp style font time roman time serif margin text align center exhibit definition style font time roman time serif margin nbsp style font time roman time serif margin pursuant section following term have meaning forth below extent conflicting with definition described section style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo actual development cost rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo adverse drug experience rdquo mean adverse drug experience degree then current edition guideline sect sect other corresponding relevant regulation country licensed territory table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo affiliate rdquo mean entity which directly indirectly control controlled under common control with party this agreement where purpose this definition ldquo control rdquo constitutes right cast right direct casting more than vote meeting owner that entity meeting entity director governing body right designate majority entity director member entity governing body power direct cause direction management policy entity whether through ownership voting security contract otherwise table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo additional study rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo agreement rdquo defined introductory paragraph table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo arizona license rdquo mean that certain license agreement between cancer prevention pharmaceutical llcpp arizona board regent behalf university arizona made effective amended table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo arizona technical information rdquo mean technical information defined arizona license that subject arizona license table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo authorized party rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo authorized representative rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo chair rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo challenge proceeding rdquo mean lawsuit arbitration other proceeding before tribunal including examination issue third party observation other proceeding procedure before governmental patent authority contesting validity patent claim seeking judgment declaratory otherwise determination that patent claim invalid unenforceable otherwise patentable contesting substantial nature regulatory value licensed information table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo claim rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo development rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo commercially reasonable diligence rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo comp rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo compound rdquo mean difluoromethylornithine also known eflornithine dfmo designated table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo confidential information rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo continued development rdquo defined section table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo control rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo continued development election rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo country addition amendment rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo country addition notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rdquo defined introductory paragraph table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo defendant rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo owned development rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo owned data rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo proposed country license notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo data rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo deficiency payment rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo develop rdquo conjugated verb form cognate noun form thereof mean conduct scientific technical regulatory activity including limited pharmaceutical formulation development clinical toxicological process development manufacturing clinical study include commercial manufacturing table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo development cost deficiency rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo development milestone payment rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo development termination rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo diagnostic licensed product rdquo mean diagnostic diagnostic required part treatment regimen licensed product manufacture sale offer sale importation diagnostic diagnostic alone connection with administration licensed product would covered patent claim development manufacturing regulatory approval labeling marketing sale commercialization that diagnostic diagnostic alone connection with administration licensed product been supported benefitted from access licensed information which embodies incorporates made with benefit licensed information table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo directly competing product rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo disadvantageous market condition rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo disadvantageous market condition notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo disclosure rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo disease addition amendment rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo disease addition notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo distinct formulation rdquo mean formulation compound that interchangeable formulation table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo effective date rdquo defined introductory paragraph table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rdquo mean european medicine agency successor entity thereof table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo enhanced right assumption rdquo defined subsection table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo enrollment threshold rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rdquo mean germany united kingdom france italy spain collectively table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo country rdquo mean germany united kingdom france italy spain table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo excepted matter rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo excepted matter rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo excepted matter rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo excepted matter rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo excepted matter rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo expert panel rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo extraordinary termination event rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rdquo mean united state food drug agency successor thereof table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo financial default rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo final development milestone payment rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo final enrollment threshold rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo financial default rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo first commercial sale rdquo mean with respect each country licensed territory first sale tillotts sublicensee that country licensed product based approval that country approved commercial sale administration human subject monetary compensation negotiated determined rsquo length basis table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo first enrollment target date rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo first enrollment date rdquo mean date which least twelve site phase trial anticipated effective date first patient enrolls with intent treat phase trial being understood that mere screening patient constitute enrollment table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo first enrollment threshold rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo first interim development milestone payment rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo gastrointestinal disease rdquo mean disease condition that affect organ gastrointestinal tract including liver biliary system pancreas gall bladder table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo indicated disease rdquo mean primary indication disease secondary indication disease additional gastrointestinal disease that party include within scope this definition manner provided subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo indirectly competing product rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo infringer rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo infringing activity rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo initial development plan rdquo defined subsection table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo intellectual property right rdquo mean right granted under applicable person with respect work authorship including without limitation exclusive exploitation right copyright moral right mask work trade secret right patent patent application disclosure including without limitation reissue division reexamination extension provisionals continuation continuation part thereof design other industrial property right trademark trade dress similar right based designation origin registration application renewal extension continuation division reissue like based deriving from foregoing table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width font style font size font font style font size ldquo interchangeable formulation rdquo mean case where licensed formulation that been granted approval indicated disease fixed dose combination proposed formulation compound sulindac active ingredient single fixed dose combination wherein dose compound combination milligram sulindac dose combination milligram whole multiple both same proportion pharmaceutical formulation tablet capsule granular powder form compound font font style font size that with respect tablet capsule form dose than compound such form being frac whole number multiple dose compound being used respective licensed product clarity oral liquid form compound interchangeable formulation font table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo interim analysis rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo interim analysis report rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo issue rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo japan development cost rdquo mean total cost developing obtaining approval commercializing licensed formulation japan table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo japanese development plan rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo jointly owned data rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo withdrawal notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo license negotiation period rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo licensed field rdquo mean therapeutic treatment prophylaxis gastrointestinal disease table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo licensed formulation rdquo mean formulation containing compound fixed dose combination with sulindac free dose combination with sulindac free dose combination include product configuration which sulindac integrally packaged with compound formulation which compound intended labeled administration without concurrent administration sulindac table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo licensed information rdquo mean following information owned controlled effective date owned data excluding data generated additional study funded solely that contribute reasonably necessary development approval sale product based containing licensed formulation including know owned controlled relating formulation administration licensed formulation included licensed patent technical clinical clinical data owned controlled relating safety efficacy dosing regimen chemical physical property biological effect contraindication other aspect treating gastrointestinal disease with licensed formulation that useful exercise right granted under this agreement obtain approval country licensed territory including owned data owned development regulatory filing approval including regulatory dossier data contained incorporated referenced therein extent issued owned controlled registered name country licensed territory relating administration licensed formulation treat prevent indicated disease arizona technical information table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo licensed patent rdquo mean patent patent application identified exhibit attached this agreement patent patent application that added this agreement exhibit operation subsection divisional continuation whole part application based foregoing issued unexpired patent resulting from application described above issued unexpired amended foreign patent reissue reexamination renewal extension patent term restoration that based patent described above table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo licensed product rdquo mean pharmaceutical preparation containing licensed formulation intended labeled administration licensed field including product manufacture sale offer sale importation which would covered patent claim development manufacturing approval labeling marketing sale commercialization which been supported benefitted from access licensed information table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo licensed territory rdquo mean following country andorra austria belgium bulgaria croatia cyprus czech republic denmark estonia finland france germany greece hungary iceland ireland italy japan latvia liechtenstein lithuania luxembourg malta monaco netherlands norway poland portugal romania marino slovakia slovenia spain sweden switzerland united kingdom vatican city country that added operation subsection after effective date country that part licensed territory admitted european union that country will deemed added licensed territory automatically effective upon that country rsquo admission european union additional action notice party will required effect that addition after effective date country that part licensed territory leaf european union that country will nonetheless continue part licensed territory table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo license rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo loss rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rdquo mean federal centralized community wide drug application marketing authorization application drug submission health registration common technical document other license permit filed with issued approved regulatory authority approval which required before commercial sale licensed formulation pharmaceutical medicinal product administration human excluding pricing reimbursement approval each case together with required subsequent submission supplement amendment thereto table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo approval rdquo mean approved accepted issued regulatory authority consequent grant right sell licensed formulation licensed field pharmaceutical medicinal product corresponding related approval license registration authorization granted issued regulatory authority table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo mark rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo milestone rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo sale value rdquo licensed product mean actual billing sale that licensed product determined follows licensed product sold tillotts sublicensee third party that related party actual billing will tillotts rsquo that sublicensee rsquo actual gross invoice amount case licensed product sold tillotts sublicensee related party subsequent sale actual billing will that related party rsquo actual gross invoice amount that subsequent sale actual billing will determined based licensed product sold dosage form suitable final usage administering physician other consumer sold that form actual billing will determined converting quantity licensed product actually sold into quantity that would have been sold final dosage form multiplying that adjusted quantity customary unit price licensed product sold each pertinent country final dosage form when factually applicable taken following deduction shall deducted from actual billing determined above sale duty other governmental charge imposed upon particular sale extent included separate charge amount actual billing amount allowed credited rejection return including recall extent such licensed product replaced supplier normal customary discount including cash discount discount payors health insurance similar organization government organization rebate paid credited accrued actually taken including chargebacks mandated retroactive price reduction adjustment made under tillotts rsquo program designed enhance availability licensed product income patient each case extent actually allowed granted from billed amount charge freight postage shipping freight allowance outbound transportation cost including respective insurance paid extent included separate charge amount actual billing actual uncollectible account receivables extent reflected tillotts rsquo book billing deduction will determined accordance with accrual method accounting accordance with principle international financial reporting standard ifrs applied consistent basis other allowance deduction made including allowance deduction commission sale whatever name known purpose converting dollar sale value invoice price currency other than dollar tillotts must first determine sale value tillotts rsquo functional currency converting pertinent foreign currency thereafter convert such value into dollar then determine earned royalty payable licensed product united state currency average daily exchange rate that foreign that functional currency over calendar quarter which sale made determined reference currency converter table fxdaily published oanda subsection applicable then term ldquo tillotts rdquo this definition shall replaced with ldquo rdquo purpose determining rsquo payment obligation under subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo deductible rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo optional information rdquo mean regulatory filing approval data contained incorporated referenced therein extent owned controlled registered name with respect optional territory country that been added licensed territory operation subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo optional territory country rdquo mean following country collectively afghanistan albania armenia azerbaijan belarus bosnia herzegovenia egypt georgia iraq israel jordan kazakhstan kuwait kyrgyzstan lebanon macedonia moldova montenegro oman philippine qatar russia saudi arabia serbia tajikistan turkey ukraine united arab emirate uzbekistan table style font time roman time serif margin text indent nbsp style font time roman time serif margin text indent field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo outside field notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo patent claim rdquo mean valid claim unexpired licensed patent patent claim presumed valid enforceable unless until been held invalid unenforceable final judgment court competent jurisdiction from which appeal taken purpose this agreement especially purpose royalty determination payment under section claim being presented pending patent application deemed equivalent valid claim issued unexpired patent consideration agreement grant license under patent issuing thereon tillotts must earned royalty thereto though were issued valid patent claim table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo pediatric cancer rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo phase trial rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo pmda rdquo mean japanese pharmaceutical medical device agency that charged with regulation approval pharmaceutical medicine successor agency thereof table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo post launch period rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo price discussion notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo primary indication disease rdquo mean familial adenomatous polyposis human table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo proposed outside field license rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo reasonable commercial diligence rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo reduced sale notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo regulatory authority rdquo mean regulatory agency ministry department other governmental body having authority country region licensed territory control development manufacture pricing marketing sale product including including committee orphan medicinal product pmda table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo regulatory dossier rdquo mean filed with regulatory authority corresponding related post filing with approval authorization issued regulatory authority pertaining licensed formulation corresponding technical regulatory registration necessary conduct clinical trial licensed formulation manufacture labeling distribution marketing sale import reimbursement export licensed formulation jurisdiction regulatory authority approval regulatory authority table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo regulatory representative rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo reimbursed price rdquo mean reimbursed price purchase licensed product final consumer licensed product established approved applicable regulatory authority table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo related party rdquo mean with respect party party affiliate person enjoying special course dealing with that party affiliate example limitation quot special course dealing quot includes marketing arrangement between party third party wherein third party sell licensed product arrangement under which third party will sell licensed product under private labeling arrangement with that party supply contract which party agrees with third party supply manufacture licensed product sale third party under such third party name mark barter arrangement which party exchange licensed product other product kind distributor licensed product under party rsquo affiliate rsquo name mark related party party affiliate share either directly indirectly proceeds from distributor sale licensed product table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo repository rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo representative rdquo mean director officer employee agent consultant attorney accountant subcontractor party affiliate party table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo reserved right rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo resolution deadline rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo restricted stock rdquo mean unregistered common stock value share table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo right first negotiation rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo right assumption rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rofn rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rofn notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rofn term sheet rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rofr acceptance period rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rofr notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo royalty term rdquo mean country country licensed product licensed product basis period commencing upon first commercial sale pertinent licensed product given country ending later date expiration last expire licensed patent pertinent country licensed territory after accounting renewal extension patent term restoration that based licensed patent pertinent licensed product latest date expiration data market exclusivity conferred pertinent licensed product pertinent country licensed territory expires whether based orphan designation other regulatory exclusivity date that twelve year from date first commercial sale first licensed product that country table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo sale milestone payment rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo second enrollment target date rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo secondary disease development plan rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo secondary disease interim election date rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo secondary disease final election date rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo secondary disease notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo secondary disease notice rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo secondary indication disease rdquo mean colon adenoma human table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo second enrollment threshold rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo second interim development milestone payment rdquo defined subsection table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo sell rdquo cognate noun form conjugated verb form thereof mean sell otherwise part with dispose value whether cash proceeds barter service value licensed product deemed sold upon transfer title licensed product from seller buyer table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo senior representative rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo significant quantity rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo sublicense rdquo mean sublicense granted under section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo sublicensee rdquo mean third party which right granted under sublicense table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo supplemental country development plan rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo supplemental disease development plan rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo supply agreement rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo term rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo term sheet period rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo third enrollment target date rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo tillotts rdquo defined introductory paragraph table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo tillotts audit matter rdquo defined section table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo tillotts owned development rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo tillotts owned data rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo tillotts patent right rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo total annual sale value rdquo mean aggregate sale value quarterly sale value properly calculated accordance with section summed across licensed product sold used imported into licensed territory given calendar year more tillotts affiliate sublicensees table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo total development cost rdquo mean total cost incurred after august developing licensed formulation according initial development plan latest approved version licensed territory excluding japan development cost cost conducting additional study table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo total enrollment target rdquo mean total number patient targeted enrollment phase trial specified protocol table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo transfer price rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo transfer price proportion rdquo defined subsection table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo rdquo cognate noun form conjugated verb form thereof mean commercial purpose table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo valuation expert panel rdquo defined subsection table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo wind down expense rdquo mean development licensed formulation primary indication disease licensed territory pocket expense returnable already accounted material that received before date that termination notice under this agreement given pocket expense accountable during three month period immediately following date that notice termination given which subject cancellable commitment under contract purchase order service agreement made issued before date that termination notice under this agreement given rsquo internal cost including associated related development licensed formulation licensed territory three month period immediately following date that notice termination under this agreement given cost related cancellation termination return respective commitment contract material long such cost lower comparison cost related fulfillment such contract those cost shall accountable wind down expense only such commitment contract reflect market standard condition table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width ldquo wind down statement rdquo defined subsection table style font time roman time serif margin text indent nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin text align center nbsp style font time roman time serif margin text align center exhibit ndash surviving provision style font time roman time serif margin text align center nbsp style font time roman time serif margin pursuant section this exhibit forth certain specific provision agreement that survive expiration termination style font time roman time serif margin nbsp table cellpadding cellspacing style font time roman time serif margin margin bottom style vertical align text align justify style width style width text align left style text align justify expiration termination table style font time roman time serif margin nbsp style font time roman time serif margin following provision survive expiration termination agreement style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align center section number nowrap style width nbsp nowrap style width border bottom black solid section title style vertical align style text align center nbsp term solely extent surviving reporting payment obligation forth style vertical align style text align center nbsp confidentiality regard licensed information style vertical align style text align center nbsp bridge financing total development cost solely extent related rsquo obligation repay tillots style vertical align style text align center nbsp trademark determination solely extent post termination assignment obligation forth style vertical align style text align center nbsp periodic report payment book record solely extent surviving payment audit record keeping obligation style vertical align style text align center nbsp data style vertical align style text align center nbsp intellectual property right style vertical align style text align center nbsp license grant tillotts owned data andtillotts owned development style vertical align style text align center nbsp inventorship style vertical align style text align center nbsp indemnification tillotts initiated proceeding enforce intellectual property right style vertical align style text align center nbsp assignment agreement license style vertical align style text align center nbsp liability limitation thereof style vertical align style text align center nbsp warranty disclaimer style vertical align style text align center nbsp defense third party claim style vertical align style text align center nbsp insurance style vertical align style text align center nbsp surviving obligation style vertical align style text align center nbsp effect termination this agreement sublicensees style vertical align style text align center nbsp reverter table style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align center section number nowrap style width nbsp nowrap style width border bottom black solid section title style vertical align style text align center nbsp miscellaneous excluding section representation style vertical align style text align center nbsp rule interpretation certain definition table style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width certain additional surviving provision upon termination tillotts table style font time roman time serif margin nbsp style font time roman time serif margin addition provision identified section above following provision survive event specified termination event style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width termination tillotts table style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width section unilateral termination tillotts table style font time roman time serif margin nbsp style font time roman time serif margin following additional provision survive unilateral termination entire agreement tillotts pursuant section style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align center section number nowrap style width nbsp nowrap style width border bottom black solid section title style vertical align style text align center nbsp action upon consequence termination ndash upon tillotts unilateral termination table style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width section termination tillotts breach immediate breach table style font time roman time serif margin nbsp style font time roman time serif margin following provision survive termination entire agreement tillotts breach pursuant section tillotts financial default pursuant section style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align center section number nowrap style width nbsp nowrap style width border bottom black solid section title style vertical align style text align center nbsp grant license under licensed patent style vertical align style text align center nbsp grant license under licensed information style vertical align style text align center nbsp exclusivity reservation right style vertical align style text align center nbsp right power sublicense style vertical align style text align center nbsp delivery style vertical align style text align center nbsp supply licensed formulation style vertical align style text align center nbsp earned royalty style vertical align style text align center nbsp sale milestone payment style vertical align style text align center nbsp periodic report payment book record table style font time roman time serif margin nbsp field page sequence style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table style page break before always margin margin bottom table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width style margin portion herein identified have been omitted pursuant request confidential treatment under rule security amended complete copy this document been filed separately with security exchange commission table field page style font time roman time serif margin nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align center section number nowrap style width nbsp nowrap style width border bottom black solid section title style vertical align style text align center nbsp payment procedure style vertical align style text align center nbsp late payment style vertical align style text align center nbsp style vertical align style text align center nbsp consequence upon breach immediate breach style vertical align style text align center nbsp payment upon termination breach immediate breach table style font time roman time serif margin text indent nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width section termination tillotts extraordinary termination event table style font time roman time serif margin nbsp style font time roman time serif margin following provision survive termination entire agreement tillotts extraordinary termination event pursuant section style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align center section number nowrap style width nbsp nowrap style width border bottom black solid section title style vertical align style text align center nbsp action upon consequence termination ndash upon tillotts termination certain extraordinary termination event style vertical align style text align center nbsp additional action upon tillotts termination certain extraordinary termination event style vertical align style text align center nbsp payment upon termination ndash development termination style vertical align style text align center nbsp payment upon termination ndash enhanced right assumption upon approval acceptance solely termination under subsection table style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width termination table style font time roman time serif margin nbsp table cellpadding cellspacing width style font time roman time serif margin margin bottom style vertical align style width style width section termination tillotts breach immediate breach table style font time roman time serif margin nbsp style font time roman time serif margin following provision survive termination entire agreement breach tillotts pursuant section financial default tillotts style font time roman time serif margin text indent nbsp table cellspacing cellpadding style font time roman time serif width border collapse collapse style vertical align nowrap style width border bottom black solid text align center section number nowrap style width nbsp nowrap style width border bottom black solid section title style vertical align style text align center nbsp action upon consequence termination ndash upon termination tillotts breach style vertical align style text align center nbsp payment upon termination ndash termination tillotts breach immediate breach table style font time roman time serif margin nbsp field page sequence option last style margin margin bottom border bottom black solid table cellpadding cellspacing style border collapse collapse width font size style vertical align text align left style width nbsp style width nbsp style width nbsp table field page style font time roman time serif margin nbsp body html text document